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The Greek   God, Asklepios sitting along with his daughter Hygia for healing the 
afflicted. It is from this famous statue, the symbol of Medicine and Pharmacy originated. 
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 Abstract 
Medicinal plants are being used since antiquity to treat variety of diseases. 
Several medicinal plants have been reported to have effect on immune system. 
The prime objective of ayurveda, one of the ancient Indian system of medicines, 
is the prevention of disease process. The different health care measures to be 
adopted by an individual are grouped together under the heading of rasayana. 
The word rasayana in Sanskrit literally implies the circulation of rasa, the nutrient. 
Rasayana is antiaging, increases the life span, promotes intelligence and 
memory and increases resistance to diseases. Rasayana plants possess various 
pharmacological properties e.g. immunostimulant, antibacterial, antiviral, anti-
inflammatory, anticancer, antirheumatics etc. 
Lagenaria siceraria (Molina) Standley is a medicinal plant and utilizable 
species. The fruits of this plant have been scientifically investigated in 
experimental animals for their analgesic, anti-inflammatory, antiasthmatic, 
antihyperlipidemic, antioxidant, antibacterial, diuretic, antidiabetic and 
hepatoprotective activities. Earlier researchers have reported several 
phytoconstituents in fruits viz saponins, flavonoids, terpenoids, tannins, 
carbohydrates etc. However there is paucity of data available on the effect of 
extracts of fruits of Lagenaria siceraria on immune system. Therefore, the 
present study was undertaken to investigate the immunomodulatory effect of 
different extracts/fractions of Lagenaria siceraria fruits in experimental animals. 
Further from bioactive fractions phytoconstituents were isolated using column 
chromatography and few of the isolates were again tested for their possible 
immunomodulatory activity.  
In present study, dried fruits of Lagenaria siceraria were extracted with 
methanol using soxhlet apparatus. The concentrated extract was then evaluated 
for its possible immunomodulatory activity in rats using different 
immunomodulatory protocols such as haemagglutination antibody titre, carbon 
clearance and cyclophosphamide-induced myelosuppression. The extract was 
found to increase antibody titre significantly. It also enhanced rate of carbon 
clearance from animals‟ blood indicating increased phagocytosis. A significant 
 increase in white blood cell count was observed in methanol extract-treated rats 
as compared to cyclophosphamide treatment alone.      
After confirming the preliminary immunomodulatory activity, another batch 
of dried powder was successively extracted with petroleum ether (60-800), 
dichloromethane, chloroform and methanol. Methanol extract was then 
suspended in water and fractionated with ethyl acetate and then n butanol in a 
separating funnel to enrich successive methanol extract into flavonoids and 
saponins respectively. Petroleum ether extract, dichloromethane extract, ethyl 
acetate soluble fraction and n butanol soluble fraction were then investigated for 
their immunomodulatory activity in experimental animals using following animal 
models: haemagglutination antibody titre, delayed type hypersensitivity reaction 
and haematological parameters. Out of them only ethyl acetate and n butanol 
soluble parts of successive methanol extract were found to be effective. They 
showed promising immunomodulatory activity.  
Bioactive fractions were then tested chemically to know the presence of 
different chemical constituents. TLC and HPTLC studies were also performed to 
know the number of constituents present in both fractions. Both fractions were 
then applied separately to glass column chromatography on silica gel (60-120 
mesh) to separate possible phytoconstituents by variety of mobile phases. Total 
five components were isolated in significant quantities and their characterization 
was done using different spectral techniques (1H-NMR, 13C-NMR, IR and UV 
analyses) to reveal their identity as oleanolic acid (I), β sitosterol (II), campesterol 
(III), isoquercitrin (VI) and kaempferol (VII). Two of the isolates namely I and VI 
were tested pharmacologically to assess their effect on immune system using 
animal protocols viz haemagglutination antibody titre, delayed type 
hypersensitivity reaction and carbon clearance parameters. Isolates displayed 
significant immunomodulator activity.  
The present study was planned to isolate phytoconstituents from 
Lagenaria siceraria fruits with minimum side effects and toxicity as compare to 
synthetic drugs that may offer immunostimulant or immunosuppressant action. 
Both these effects have significant role in the management of various diseases  
 e. g. immunostimulants will be helpful in the prophylaxis and treatment of some 
immuno-compromised diseases such as AIDS etc. and against infectious 
diseases, whereas immunosuppressants would show potential in combating 
autoimmune diseases such as systemic lupus erythematosus, myasthenia gravis 
as well as hypersensitivity, graft rejection etc. The identified constituents may 
serve as lead compound for synthetic procedures. To the best of our knowledge, 
for the first time, we reported the immunomodulatory property of the fruits of 
Lagenaria siceraria.  
The present study with Lagenaria siceraria fruits leads us to conclude that 
crude methanol extract augments humoral immune response, activates 
macrophage-induced phagocytosis and prevents cyclophosphamide-induced 
myelosuppression.  
Our studies show that Lagenaria siceraria fruits contain flavonoids 
(isoquercitrin, kaempferol), β sitosterol, campesterol and oleanolic acid; which 
may account at least in part for their application in folk medicine. This is the first 
report on the presence of isoquercitrin, oleanolic acid and kaempeferol in the 
fruits of Lagenaria siceraria. The present study leads us further to conclude that 
oleanolic acid and isoquercitrin augment humoral immune response, suppress 
cellular immune response and activate macrophage-induced phagocytosis. Our 
findings are in agreement with the previously published reports of 
pharmacological activities of fruits of Lagenaria siceraria, involving immunological 
background, as also mentioned by many other researchers like anti-
inflammatory, antibacterial, antioxidant and antihepatotoxic.   
The results obtained in the present study shown that these extract, 
fractions and phytoconstituents display significant immunomodulatory effects. 
Besides from the obvious therapeutic importance, these components would be 
useful in understanding the mechanism of diseases with higher levels of cellular 
activation, such as autoimmune and hypersensitivity reactions. These 
components could serve as lead molecules for development of potential 
immunomodulators. Further detailed studies are required to elucidate the exact 
mechanism responsible for immunomodulatory activity of Lagenaria siceraria 
 fruits. The present findings are significant for the development of alternative, 
inexpensive and perhaps safer strategies for the treatment of diseases requiring 
use of immunomodulatory agents.  Further work on the chemical isolation and 
structure determination of the compounds from bioactive fractions in order to find 
the structure activity relationship is warranted.    
Since secondary metabolite content may vary as a function of multiple 
factors, such as environmental conditions and harvest period, reproduction of this 
analysis over a long period of time is needed before the effectiveness of our 
method is totally demonstrated.  
Although no immunomodulatory drugs to date have demonstrated 
overwhelming clinical efficacy in the absence of toxicity, our increasing 
knowledge of immunopharmacology is cause for great optimism that future 
agents will provide an important addition to the physician‟s armamentarium.  
 
Key words: Lagenaria siceraria fruits, Immunomodulatory, Cucurbitaceae, 
Isoquercitrin, oleanolic acid.   
  
 
 
 
 
 
 
 
 
 
Chapter 1 
Introduction 
  
1. Introduction 
When Nalanda (world’s first residential university in Patna; present Bihar‘s 
capital in India, now no more exists) was at its best, Jeevat, a student, 
approached his guru Acharya Bhadanta for final certification. He was 
advised to search for any vegetation that was of no medicinal value. Jeevat 
sincerely observed, experimented, analyzed and finally inferred that there 
was none without some use. He was given his graduation certificate1.  
 In recent years there has been great interest in the pharmacological 
manipulation of the immune response. Selective pharmacological action on an 
individual component of a complex immune response is seen as a particularly 
attractive approach to the therapy of immunologically mediated diseases2.  The 
control of disease by immunologic means has two objectives: the development of 
immunity and the avoidance of undesired immune reactions. Modification of 
immune function by pharmacological agents is emerging as a major area of 
therapeutics in those cases where undesired immunosuppression is the result of 
therapy. On the other hand undesired immunostimulation is a common side 
effect with drugs like quinine, salicylates, indomethacin etc3. Stimulation of 
nonspecific defense mechanisms of human beings as one concept of therapy 
has a long tradition in medicine. Injections of body‟s own blood, milk, protein, 
suspensions of inactivated microorganisms, injections of animal or plant extracts 
as well as administration of inflammatory agents such as mustard oil, turpentine 
oil etc., have been used for general reorientation4. 
 Current cancer therapy; such as surgical excision, radiotherapy and 
chemotherapy are limited and alternative treatments are required for patients 
who fail to respond to these therapies5. The most common cause of death in 
patients with malignancies is infection. This is due to a combination of factors, 
prime among them being the immunosuppression induced by the 
chemotherapeutic agents. There are varieties of naturally and chemically derived 
 compounds (discovered with immunomodulatory activity) such as levamisole, 
glucan, IL-2, IFN etc. which are used in combination with cisplatin, adiramycin, 5-
flurouracil etc. against many types of carcinomas6. But most of these compounds 
have side effects namely fever, myalgias, fatigue etc. It is well known that 
antitumor drugs such as anti-metabolites and alkylating agents such as 
cyclophosphamide cause various kinds of side effects including 
immunosuppression, bone marrow injury and digestive system dysfunction. The 
immunosuppression and injury of the bone marrow by the drugs will reduce not 
only immunological defense functions against microorganisms but also 
immunological resistance against tumors. Such suppressive activities of 
antitumor drugs are paradoxical and are serious side effects from the view point 
of the therapeutic efficacy of drugs7. Further, substances like ubiquinone, 
muramyl dipeptide and its derivative, endotoxin and bacterial products like BCG 
have been reported to enhance host defense. However, a safe and effective drug 
is yet to be found8.  
 
1.1 Immune system 
The human immune response is a highly complex and extraordinarily 
sophisticated system involving both innate and adaptive mechanisms. Immune 
system is a network of cells and organs that work together to defend the body 
against attacks by foreign individuals. The degeneration and atrophy of immune 
organs will influence the normal functions of the whole immune system9. 
Immunoregulation is a complex balance between regulatory and effector cells 
and any imbalance in the immunological mechanism can lead to pathogenesis. 
The immune system is involved in the etiology as well as pathophysiologic 
mechanism of many diseases. Immunomodulators have great promises in the 
prevention and treatment of wide range of diseases of; skin, gut, respiratory tract, 
joints and central organs. The function and efficiency of the immune system may 
be influenced by many exogenous factors like food, drugs, physical and 
psychological stress and hormones etc. resulting in either immunostimulation or 
immunosuppression. The healthy state is believed to be based on a 
 sophisticated fine-tuning of immunoregulatory mechanism. Presently available 
drug have side effects such as myelosuppression10 and are expensive11. 
Moreover constant increase in antibiotic resistant strains of microorganisms has 
prompted scientists to look for herbal immunomodulators to treat various 
infections12. Modulation of immune functions using medicinal plants and their 
products as a possible therapeutic measure has become fundamental principles 
of therapeutic approach. 
 
1.1.1 Cell mediated immunity 
 TH1 cells are T lymphocytes that belong to the CD4
+ subset. They 
participate in cell-mediated immunity, which is essential for controlling 
intracellular pathogens like viruses and certain bacteria.  Antigen presentation by 
dendritic cells (DCs) to the T cell receptors (TCRs) of premature CD4+ TH cells, 
coupled with secretion of IL-12, indicates TH1 cell production. IL-12 stimulates 
TH1 cells to secret their own lymphokines, including tumor-necrosis factor-beta 
(TNF-β) and interferon gamma (INF-γ). These cytokines stimulate macrophages 
and the recruitment of leukocytes to the site, resulting in inflammation. TH1 cell 
action together with NK cell and macrophage activity maintain a complex 
signaling cascade whose vital goal is the effective destruction of target cells, 
especially virally infected or stressed host cells. In order to reinforce the TH1 
immune response, the TH2 responses are suppressed in two ways. First, IFN-γ 
and IL-12, secreted by TH1 cells, inhibit the formation of TH2 cells. Second, IFN- γ 
inhibits class-switching in B cells.  
 1.1.2 Humoral immunity                              
The humoral immune system affords the ability to adequately protect the 
host from unanticipated pathogens. This system is made possible through the 
generation of a plethora of receptors which can recognize a wide array of 
antigens. TH2 cells are produced in a manner similar to TH1 cells, but with 
different cytokines. TH2 cells provide help for B cells and are essential for 
antibody-mediated immunity, which is needed to control extracellular pathogens. 
B cells have specialized receptors which bind and engulf soluble antigens 
 through receptor-mediated endocytosis. The antigen is digested into fragments 
which are then displayed at the cell surface within a class II histocompatability 
molecule. TH2 cells with complementary TCRs bind the B cell and secrete 
lymphokines that induce B cell differentiation into a clone of plasma cells that 
secrete identical antibodies. These antibodies recognize and bind to an epitome 
on an antigen and trigger a constructive response to the antigen. TH2 cells 
secrete four major lymphokines. IL-4 stimulates class-switching in B cells to 
promote synthesis of IgE antibodies and promotes premature TH cells to enter 
the TH2 pathway while simultaneously inhibiting the TH1 differentiation pathway. 
IL-5 recruits and activates eosinophils at the site of action. IL-10 inhibits IL-12 
production by DCs therefore adding another inhibitory mechanism to the TH1 
differentiation pathway. Like IL-4, IL-13 also promotes the synthesis of IgE 
antibodies13.  
         
1.2 Disorders associated with immune system 
It has been proved that several diseases like rheumatoid arthritis, ulcerative 
colitis and liver ailments have an immunological background14. Plants which are 
effective in treating chronic infection such as fever and immunological disorders 
such as asthma and rheumatism have been screened for their 
immunomodulatory effects15. Immunomodulation is an integral part of 
multifaceted effects of rasayana and is closely liked to adaptogenic, anabolic and 
antioxidant activities 14. Herbs that are rich in flavonoids, vitamins C or the 
caretenoids may enhance immune function. The flavonoids rich herb may also 
possess mild anti-inflammatory action16. Immunomodulators isolated from plants 
also possess antioxidant property17.            
 The attenuation of inflammation and the enhancement of cell mediated 
immunity are just two of several potential therapeutic means to treat disease 
pathology using natural products that modulate the immune system13.  
Inflammation, defined as the response of living tissue to injury, and characterized 
by the cardinal signs of rubor, calor, dolor and tumor, comprises the vascular and 
cellular responses of the organism to infection, tissue injury and intrusion of 
 foreign materials. Inflammatory responses are essentially oriented towards the 
elimination of dead tissue, microbes, toxins and inert foreign substances. 
Inflammatory diseases may be due to the pathological manifestations of 
reactions directed against foreign bodies, notably microbes. They may also be 
due to an abnormal response toward normal body constituents. Auto-immune 
diseases are most commonly associated with infiltrates of mononuclear cells 
associated with an inflammatory reaction. More generally, inflammation and 
immunity are closely interrelated: most inflammatory reactions, even those 
induced by non-antigenic substances, have an immunological component, and 
some effector mechanisms are responsible for both inflammation and immunity. 
Immunity can be said to focus inflammatory reactions on specific targets, thus 
enhancing their efficiency and speed of onset. Immunity may also contribute to 
the regulation of inflammatory processes. It may shorten or prevent an 
inflammatory reaction by removing the stimulus for inflammation, or it may 
enhance an inflammatory reaction via the numerous amplifier mechanisms of the 
immune system. Conversely, the majority of immunologically mediated diseases 
are inflammatory in nature. The pathological features of antibodies are 
summarized in Table 1.             
Table 1: Pathogenic effects of antibodies 
 
                                                        Cell destruction 
Cytolysis  Autoimmune hemolytic anemia  
Opsonization  Autoimmune thrombocytopenic 
purpura and autoimmune hemolytic 
anemia  
Antibody-dependent cellular 
 cytotoxicity 
Thryoiditis 
                                              Alteration of cell function 
Blockage of a functionality-relevant molecule 
         In the circulation Anticoagulant  
         In the cell membrane  Rheumatoid factors (RA) 
 Antigenic modulation  Myasthenia gravis  
Cellular stimulation Graves‟ disease 
                                                Hypersensitivity 
I Immune complex formation      
          Local  
          Systematic  
Basophil and mast cell degradation  Allergic asthma 
Anaphylaxis  Drug-induced allergy  
 
 The treatment of immunologically-mediated inflammatory diseases may be 
considered at several levels. Action at the peripheral level by anti-inflammatory 
agents represents the easiest approach, and is often satisfactory and sufficient in 
itself, especially in rheumatoid arthritis. Immunosuppressive agents, especially 
steroids, are useful, but act non-specifically. It is to be hoped that a better 
appreciation of their immunosuppressive and anti-inflammatory activities will be 
gained in future, particularly for steroids (when only anti-inflammatory drugs should 
be used). Despite the problem of toxicity and xenoimmunization, that limit the 
present use of selective drugs such as cyclosporine A, which acts selectively on 
helper-T cells or monoclonal anti -T- cell antibodies, it is also to be hoped that 
more of these drugs will be found. Consideration should be given to 
immunomodulatory drugs for the restoration of physiological T cell balance18.  
 
1.3 Immune system and CAM (complementary and alternative medicine) 
Alternative medicine practices are gaining increasing attention in both 
consumer and scientific circles. Alternative medicine is defined as those 
therapies or practices outside of the realm of conventional medical practice as 
taught in most US medical schools and offered in most US hospitals.  
The medicinal botanicals with the longest tradition and for which extensive 
data are available are Chinese herbal medicine and their Japanese counterparts-
kampo medicines. Recorded history on the use of plant and plant extracts for 
medicinal purpose in China dates as far back as 2800 BC, when the medical text 
Chen Noug Pen T‟ sao was published. Many traditional Chinese medicines have 
been adapted in Japanese Kampo medicines, which are now available by 
prescription in Japan. Panax ginseng and Ginkgo biloba‟s medicinal potential 
was explored first time by China in the world. Some noted Chinese herbal 
formulations with proved immunomodulatory activity are: Juzen-taiho-to, 
Shosaiko-to, saiboku-to, Sho-seiryu-to, Shigyaku-to, Kakkon-to, glycrrhizin, 
Ninjin-youei-to etc19.  
A variety of homeopathic remedies have been utilized for hundreds of 
years, without any scientific evidence of efficacy, for the treatment of immune 
 system-related disorders. Modern technologies have afforded the ability to 
identify a number of immunomodulatory compounds, isolated from plant and 
fungi, and to elucidate their mechanism of action. A great deal of these 
compounds has been shown to stimulate or suppress the immune system via 
direct or indirect Treg cell modulation besides other immune cells
13.      
     In the past living and attenuated microorganisms, autologous and 
heterologous proteins and injections of animal organ preparations were used with 
the aim of restoring an impaired defense mechanism. At present also, thymus 
peptides and other biological response modifiers, synthetic low molecular weight 
compounds (e.g. levamisol), chemically modified nucleotides, polysaccharides 
from fungi (e.g. lentinan) and especially in Europe and China, some plant 
extracts are also used for the same purpose20.  
The field of study in immune enhancing compounds is relatively new, 
natural products represent a rich and promising source of novel molecules with 
immunomodulating properties. Professor Hildebert Wagner, of the University of 
Munich, the world‟s most distinguished researcher on adaptogen and 
immunomodulating agents from plants, including a significant amount of research 
on echinacea and Uncaria tomentosa, has published over 800 papers including 
several reviews in this field, besides a textbook on plant immune-modulating 
agents. Co-evolution between plant and their natural enemies including insects, 
bacteria, fungi, nematodes, animals, humans and viruses is considerably more 
far reaching than current theories of reciprocal interaction suggest. In order to 
adapt to environmental insults, plants produce a vast number of products that 
have antimicrobial and immunomodulating potential. These include isoflavonoids, 
indoles, phytosterols, polysaccharides, sesquiterpenes, alkaloids, glucans, 
tannins, a variety of vitamins and trace minerals that function as antioxidants and 
co-enzymes and many other phytochemicals. There are a number of parallels 
between plant immunological activity and the immune system of mammals, 
including adaptive mechanisms for viral resistance. Both the attribute of 
reciprocal natural co-evolution and the concept of shared chemistry among 
species are characteristics that allow humans to use plants as antiviral and 
 immunomodulating medicines. In an age of emerging new viruses (recent 
outbreak of swine flu virus) with stunning virulence, natural antiviral and 
immunomodulators could play a pivotal role in human diseases prevention and 
treatment21.          
The Brazilian folk medicine, sucupira seed, which has been used for 
attenuation of inflammation, has shown clinical and immunomodulatory effects in 
collagen II-induced arthritis in mice. Suppression of B cell and CD4 T cell 
activation, by sucupira seed extracts, lends evidence for its usage in chronic 
inflammatory diseases13.  
  The severe debility and immune dysfunction associated with serous 
diseases may respond to treatment with the tonic formulae from traditional 
Chinese medicine (TCM). One of these, ginseng and dang gui ten combination 
has gained prominence as the formula most suitable to assist convalescence 
after chemotherapy and radiotherapy. Some of these herbs may be used in fairly 
high doses to actively support the body to fight the cancer; others are more 
employed to support the body cope with the symptoms of cancer or the side 
effects of conventional cancer treatments19. Popular demand for and scientific 
interest in complementary or alternative medicine, particularly medicinal 
botanicals, has increased considerably in recent years.  
It has been well known since ancient times that complementary and 
alternative medicine (CAM), including exercise, provides a lot of benefit to health. 
Many CAM modalities are believed to prevent or even cure diseases, especially 
morbid ones such as cancer. However, until recently conventional medicine has 
largely rejected the use of CAM agents because little biological evidence has 
been provided for the functional mechanisms of many of them. For the past few 
decades, the value of CAM has been rediscovered by many modern researchers. 
Modulation of immune function by CAM agents is the mechanism most widely 
analyzed and has been suggested to provide some scientific evidence for the 
biological effects of various CAM agents. Specifically, evidence for up-regulation 
of natural killer (NK) cell numbers and/or NK cell cytotoxicity by these agents has 
been accumulating. NK cells have been well established as innate cytotoxic 
 effector cells for self defense in both vertebrates and invertebrates, in both of 
which they may use seminal mechanisms in the lysis of target cells. Such CAM 
modalities include oriental medicine, especially traditional Chinese medicine 
(including acupuncture), extract products from plants, animals. In particular, 
many investigators have suggested that NK cell activation is one of the critical 
mechanisms for the biological effects induced by various CAM agents; e. g. 
intake of green tea and some kind of live lactic acid bacteria enhanced NK cell 
activity. Administration of extracts from ginseng, aged garlic, Viscum album, 
Cichorium intybus, Echinacea pupurea root, Derris scandens, some wild plants, 
and some kind of mushrooms significantly augmented NK cytotoxicity or restores 
NK cell activity in some immune-suppressive conditions. The precise 
mechanisms of NK cell activation by CAM agents have not been clearly defined. 
The two main possibilities are: 1) augmentation of cytotoxic molecules in NK cells 
and/or 2) up-regulation of activating NK cell receptors and/or down-regulation of 
inhibitory NK cell receptors22.   
 
 
 
1.4 Immunomodulators   
Immunomodulating activity refers to biological or pharmacological effects of 
compounds on humoral or cellular aspects of the immune response20.  
Modulation of immune response through stimulation or suppression may help in 
maintaining a disease free state23. Apart from being specifically stimulatory or 
suppressive, certain agents have been shown to possess activity to normalize or 
modulate pathophysiological processes and are hence called immunomodulatory 
agents24.  Few related terms are:   
1.4.1 Immunosuppressants: Immunosuppression implies mainly the decrease 
in resistance against infections, stress and may occur on account of 
environmental or chemotherapeutic factors25.    
Clinical applications of immunosuppressant26:   
  To suppress rejection of transplanted organs and tissues (kidney, bone 
marrow, heart, liver, etc.) 
 To suppress graft-versus-host disease (i.e. response of lymphocytes in 
the graft to host antigens) in bone marrow transplants. 
 To treat a variety of conditions, which, while not completely understood, 
are believe to have an important autoimmune component in their 
pathogenesis. These include idiopathic thrombocytopenia purpurea, some 
forms of hemolytic anemia and glomerulonephritis, myasthenia gravis, 
systemic lupus erythematosus, rheumatoid arthritis, psoriasis and 
ulcerative colitis. 
 Selective immunosuppression for prevention of Rh hemolytic disease of 
the newborn. 
1.4.2 Immunostimulants: The term immunostimulation comprise a prophylactic 
or therapeutic concept which aims at the stimulation of our nonspecific immune 
system. This implies primarily the non antigen dependent stimulation of the 
function and efficiency of granulocytes, macrophages, complement and natural 
killer (NK) cells. In contrast to immunity achieved by immunization or antibody 
injection, this type of immunity, arising from unspecific immunostimulation, is 
termed paramunity and the agents responsible are known as paramunity 
inducers. It is characteristic for these agents that they do not affect 
immunological memory cells. Their pharmacological efficacy fades away quickly 
and must therefore be renewed by administering the drug either in intervals or 
continuously20.     
Clinical uses of immunostimulants are in treatments of diseases like26   
 Immunodeficiency disorders such as AIDS 
 Chronic infectious diseases 
 Cancer 
 
1.4.3 Rasayana: Ayurveda is one of the oldest systems of traditional medicines, 
originated in India. As per ayurveda, rasayana drugs act on immune system. On 
ingesting the appropriate formulation of the rasayana in the appropriate season 
 under the supervision of a qualified ayurvedic physician, the beneficial effects of 
rasayana are seen. Brahma rasayana, amruthaprasham and narsimha rasayana 
were found to enhance proliferation of lymphocyte in response to mitogens. 
Natural killer cell activity was also enhanced in both normal and tumor bearing 
animals. Acharya Charaka has stated that the method of rasayana was, for our 
sages, just like nectar to angels in heaven. With the help of rasayana they were 
able to live for thousands of year, transcending old age, infirmity, diseases and 
even death. Rasayana therapy in general has a relevance to both health 
(kamaya rasayana) and the ailing (naimitika rasayana).The latter kind of therapy 
helps in relieving from different diseases in short time by enhancing the vital 
power, vigor and immunity of diseased person. Patient on naimitika rasayana will 
develop specific capacity to fight with particular disease.  
An entire section of materia medica of ayurveda is devoted to rasayana 
plants. Thirty four plants have been identified as rasayana in the ayurvedic 
system (Table 2). These plants possess various pharmacological properties viz. 
immunostimulant, antibacterial, antiviral, anti-inflammatory, anticancer, 
antirheumatic etc. Besides these, several medicinal plants, which are not 
included as rasayana in ayurveda, have also been found to possess 
immunomodulatory properties as mentioned in Table 414.       
  Table 2: List of rasayana plants  
                                                 Rasayana plants 
Acorus calamus (Bach) Glycerrhiza glabra (Yashtimadhu) 
Allium sativum (Lahsuna) Gmelina arborea (Gamari) 
Aloe vera (Ghrit-kumari) Hemidesmus indicus (Anant mul) 
Argyreia speciosa (Samander ka pat) Ipomoea digitata (Ajvayan) 
Asparagus racemosus (Satawar) Leptadenia reticulate (Dori) 
Azardirachta indica (Nimba, Neem) Piper longam (Piplamul) 
Bacopa monnieri (Brahmi) Plumbago zeylanicum (Chita) 
Boerhavia diffusa (Sant) Psoralea corylifolia (Babchi) 
Cissampelos pareira (Akanadi) Pterocarpus marsupium (Bijasar) 
Commiphora mukul (Guggul) Semecarpus anacardium (Bhiawa) 
Convolvulus pluricaulis (Shankhpushp) Sida spinosa (Gulsakari) 
Curculigo orchioids (Krishna musali) Solanum nigrum (Makoi) 
Curcuma longa (Haldi) Sphaeranthus indicus (Mundi) 
Desmodium gangeticum (Shalaparni) Terminalia belirica (Bahera) 
Dioscorea bulbifera (Ratalu) Terminalia chebula (Haritaki/Panhar) 
Emblica officinalis (Amla) Tinospora cordifolia (Guduchi) 
Emblica ribes (Vidanga) Withania somnifera (Ashwagandha) 
 
 
  Table 3: List of non rasayana plants 
                                                       Non  Rasayana plants 
Abrus precatorius (Gunja) Hibiscus esculentus (Bhindi) 
Aconitum hetrophyllum (Atis) Holarrhena antidysenterica (Kurchi) 
Albizzia lebbeck (Shrisha) Hoppea dichotoma  (Kuki) 
Amoora rohituka (Harin-hara) Hyoscyamus niger (Parsikaya) 
Andrographis paniculata (Kalmegh) Jasminum sambac (Motia) 
Aristolochia indiac (Isharmul) Lawsonia innermis (Mehndi) 
Artocarpus lakoocha (Dahua) Luffa actangula (Turai) 
Astragalus multiceps (Sarmul) Luffa cylindrical (Ghia tarui) 
Bauhania variegate (Kachnar) Mallotus philippinensis (Kamala) 
Berberis aristata (Dar-hald) Mangifera indica (Aam) 
Blechnum orientale (Rajhans) Manilkara kauki (Khirni) 
Bombax malabaricum (Simul) Melia azadirachta  (Bakain) 
Bupleurum falcatum (Sipil) Metha spicata (Pudina) 
Butea monosperma (Dhak) Mucuna pruriens (Kaunch) 
Butea superba (Palas)  Nardostachys jatamansi (Jatamansi) 
Calotropis procera (Madder) Nelson campesiris  (Patta kamraj) 
Carissa carandus (Karaunda) Ocimum canum (Mamiri tulsi) 
Catharanthus roseus (Sada bahar) Ocimum sanctum (Tulsi) 
Celastrus paniculatus (Malkangi) Ougeinia oojeinensis  (Sandan) 
Centella asiatica (Madukaparni) Picrorrhiza kurroa  (Kutaki) 
Cicer arietinum (Chana) Piper aurantiacum (Shambhatuka) 
Citrullus colocynthis (Indrayan) Piper betel (Paan) 
Clerodendrum infortunatum (Bhant)  Pluchea lanceolata  (Sorahi) 
Clitoria ternatea (Aparajita) Prosopis spicigera (Jhand) 
Costus speciosus (Keu) Randia dumetorum (Maniphal) 
Cucumis sativus (Khira) Saraca indica (Ashoka) 
Cuminum cyminun (Jeera) Selaginella bryopteris (Amarbooti) 
Cymbopogon maritinii (Gandh) Solanum trilobatum (Agnidamini)  
Dryopteris cochleata (Jatashankar) Syzygium cumini (Jamun) 
 Elephantopus scaber (Gobhi) Valeriana  wallichi (Tajar) 
Elytraria acaulis (Sahustra muli) Viscum album (Banmda) 
Eupatorium cannabinum (Tongollati) Vitex negundo (Nirgandi) 
Falcourtia indica (Bilangra) Woodfordia fruticosa (Dhal) 
Gymnema sylvestre (Medhasinghi) Zingiber officinalis  (Adarak) 
 Table 4 enlists the plants with their immunomodulatory constituents and mode of 
action26: 
Table 4: Phytoconstituents with proven immunomodulatory activity along 
with their sources and mode of actions 
Plant name Constituents Mechanism of actions 
Alkaloids   
Aristolochia clematitis Aristolochic acid Enhances phagocytosis 
Stephania cepharanthe Cepheranthine Stimulates antibody 
production 
Cephaelis ipecacuanha Emetine Increases 
microphagocytosis 
Catharanthus roseus Vincristine Induces antibody 
production 
Camptotheca acuminate Camptothecin, tenulin Induce interferon 
Production of antibodies 
Nathopodytis foetida Camptothecin Induce interferon 
Uncaria tomentosa Isopteropodin, pteropobin Immunosuppression(high 
dose), immunostimulant 
(low dose) 
Phellodendron amurens Phellodendrine Immunosuppressant 
Glaucium flavum Oxoglaucine Immunosuppressant 
Claviceps purpurea Ergot alkaloids Immunomodulation 
Berberis poieretii Berbamine Immunosuppression  
Berberis aristata Berberine Enhances phagocytosis 
Withania somnifera Withaferin A Activates antibodies 
Sophora flavescens Matrine, oxymatrine Immunomodulation 
Aconitum hemeleyanum Yunaconitine Stimulates phagocytosis 
Sinomenium acutum Sinomenine Anti complement action 
Saponins   
Panax ginseng Ginsengoside Rg I Proliferates  lymphocytes 
Glycyrrhiza glabra Glycyrrhizin Increases spleen weight 
 Aralia mandshuria Oleanolic acid Increases phagocytosis 
Enzyme   
Manda enzyme  Increases spleen index 
Phenol and quinoids   
Azadirachta indica Catechins Enhances phagocytosis 
Tabeuhia avellana Quinines,ubiquinones, Increases phagocytosis 
Jatropha multifida Multifidol mutifidol -α-D-
glupyranoside 
Inhibits complement 
activation 
Okoubaka aubrovillei Epicatechin gallate, 
epigallocatechin gallate 
Stimulation of 
granulocyte 
Casearia guianensis Casearinols A &B 
casearinones A & B 
Immunomodulation 
Plumbago zeylanicum Plumbagin Stimulates phagocytosis 
Lawsonia alba Lawsone Stimulates phagocytosis 
Alkanna tinctoria Alkannin Stimulates phagocytosis 
Maesa lanceolata Maesanin Stimulates phagocytosis 
Cleistanthus collinus Cleistanthin Increases phagocytosis 
Curculigo orchioides Curculigoside Increases phagocytosis 
Gossypium herbacium Gossypol Induces interferon 
Pimpinella anisum Anethole Increases leukocytes  
Lectins   
Viscum album Viscumin Stimulates lymphocytes 
Canavalia ensiformins Concavolin A Stimulates lymphocytes 
Peptides   
Linum usitatissimum Cyclolinopeptide B Immunosuppression 
Artemisia princes Protein Induces interferon 
Amantia muscarina α- amanitin Induces interferon 
Polysaccharides   
Echinacea purpurea A heteroxylan with1α4α 
linked xylose,rhamnogalactan 
Stimulates phagocytosis 
Calendula officinalis A heteroxylan Stimulates phagocytosis 
 Eupatorium perfoliatum A heteroxylan Stimulates phagocytosis 
Acanthopanax senticosus A glucan and a heteroxylan Stimulate phagocytosis 
Chamomilla recutita Xylose & 4-o-methyl 
glucuronic acid 
Stimulate phagocytosis 
Achyrocline saturoioides Xylose & 4-o-methyl 
glucuronic acid 
Stimulate phagocytosis 
Sabal serrulata Arabinoxyloglucuronate Stimulate phagocytosis 
Picrorriza kurroa Picriside I, II , kutkoside, 
vanillic acid, apocynin 
Anticomplement activity 
Nyctanthes arbortristis Arbostristoside A & C Immunomodulation 
Curcuma longa Ukonan B Stimulates RE system 
Baptisia tinctoria A heteroxylan Enhances production of 
antibodies against SRBC 
Rhaponticum carthamoids Glucan fraction Proliferates granulocytes 
Aloe vera Acemannan Anticomplement activity 
Dipsacus asperoides Crude polysaccharide Anticomplement activity 
Rudbeckia bicolor Methanolic extract Immunostimulation 
Epimedium humanense Epimedin C Proliferates lymphocyte 
Adina rubella Rubelloside B Immunostimulation 
Tinospora cordifolia Cardioside, cardifolioside A,B  Activates macrophages 
Viscum album Viscic acid Cytotoxic 
Centellla asiatica Asiaticosides Immunostimulation 
Aegle marmelous Propelargonidin Anticomplement activity 
Annona atemoya Annonisin Immunosuppression 
Arnica montana A heteroxylan Stimulates phagocytosis 
Laminaria japonica Water soluble sugars Stimulate phagocytosis 
Angelica acutiloba Arabinogalactan Anticomplementary 
Volatile oils   
Cedrus deodara Wood oil Inhibits neutrophil 
adhesion 
 Azardirachta indica Volatile oil Activates macrophages 
Terpenoids   
Echinacea pupurea Echinadiol, echinaxanthol Stimulate phagocytosis 
Echinacea angustifolia Epoxyechinadiol, 
dihydroxynardol 
Stimulate phagocytosis 
Eupatorium perfoliatum Euperfolin, eufaliatin Stimulate phagocytosis 
Zexmenia brevifolia Zexbrevin A & B Stimulate phagocytosis 
Coriolus consor Diketocoriolin B Stimulate phagocytosis 
Tripterygium wilfordii Demethyl zeylasterol Inhibits blastogenic 
response 
Melia azedarach Phorbol 12-myristate-13–
acetate 
Stimulates phagocytosis 
Tinospora cordifolia Cardiofoliiosides A & B Activates macrophages 
Artemisia annua Artemisinin Stimulates phagocytosis 
and induces interferon 
Arnica montana Helenalin Immunomodulator 
Inula helenium 11,13-dihydroalantolacton, 
alantolacton 
Immunomodulator 
Coriolus consor Diketocoriolin B Immunomodulator 
Pseudorotium ovalis Ovalicin Immunomodulator 
Pollens and allergens 
Pollen extract 
Mangifera indica 
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Few more plants have been reported for their varied action on immune system as 
mentioned under:  
Camellia sinesis (tea): Aqueous extract slightly found to enhance neopterin (a 
sensitive marker of cell-mediated immunity) in unstimulated human peripheral 
mononuclear cells in vitro, whereas a reduction of neopterin formation was seen 
 in cells stimulated with mitogens. Clausena excavate has shown to stimulate or 
suppress the immune system affecting an enzymatic system as the electron-
transferring system resulting in an immunomodulating property, especially on 
phagocytic activity. One species, which deserves here special attention, is 
echinacea which is one of the most highly regarded immune supporting herbs. 
Indigenous to North America, it was traditionally used by native Americans for a 
variety of ailments such as cold, cough, sore throats, infections, and snake and 
insect bite. Several varieties of echinacea are available. Most seem to possess 
similar properties; however some differences in chemistry have been noted. A 
number of clinical studies have demonstrated positive results in patients given 
echinacea to help boost immune function27. Several other plants have anti-
allergic properties and this can also be categorized as immunomodulators. This 
activity could be explained on the basis of stimulation of T-suppressor cells, e.g. 
Picrorrhiza kurroa has been shown to blunt the sensitivity of guinea pigs to 
histamine and sympathomimetic amines, and prevent allergens and PAF-induced 
bronchial obstruction. Besides individual plants, many herbal formulations have 
also been described in classical ayurvedic text. Chywanprash awaleha has been 
in use for more than 4000 years as an immunity boosting polyherbal 
immunomodulator14. It is a polyherbal ayurvedic rasayana preparation described 
in Charak Samhita and contains the pulp of Emblica officinalis as the prime 
ingredient. This preparation is popularly used in India and many other countries 
as a health supplement28.     
  
1.4.4 Adaptogens: They increase the resistance to physical, environmental, 
emotional or biological stressors; restore normal physiological function to the 
body, also known as whole body tonic29. Adaptogens are believed to increase the 
capacity of the body to respond to stressful stimuli acting on response to stress 
mediators such as corticosteroids, catecholamines and nitric oxide and may act 
non-specifically as antioxidant, immunomodulator, hypoglycemic, 
hypocholesterolemic, among other actions. The term adaptogen or resistogen 
was coined by N. Lazarev in the Soviet Union to classify plants and other 
 substances that augment non-specific resistance of the body, protecting it from 
stressful factors. Adaptogens are utilized chronically to counteract stress, to 
increase physical resistance, with a view to keeping fit or to attenuate some of 
the disorders resulting from aging, such as loss of memory and of attention, 
weariness, general weakness, sexual impotence etc. They may also be used by 
healthy persons, not only prophylactically, but also to improve physical and 
cognitive performances, although the capacity of adaptogens to improve 
performance in normal individual is questionable30.   
 
1.4.5 Biological response modifiers (BRMs): BRMs are the agents that modify 
the host‟s biological response by the stimulation of immune system, which may 
result in various therapeutic effects. Some of these agents are sometimes called 
as immunomodulators. BRMs include synthetic and biological agents with a 
series of completely different chemical structures. Several herbal drugs are 
actually considered as being potent in this area26.  
They are the substances used in biological therapies. They alter the 
interaction between the body‟s immune defenses and cancer, thus improving the 
body‟s ability to fight the disease. BRMs such as cytokines and antibodies are 
the substances that occur naturally in the body, however in recent decades a 
variety of BRMs have been produced as medical agents. BRMs may be used to 
enhance a cancer patient‟s immune system, eliminate, regulate or suppress body 
responses that permit cancer growth, make cancer cells more susceptible to 
destruction by the immune responses, block or reverse the process that changes 
a normal cell or a precancerous cell into a cancerous cell, reduce the side effects 
of other forms of cancer treatment, such as chemotherapy or radiation and 
reduce the risk of metastasises. Herbal biological response modifiers include 
herbs with the actions viz adaptogen, immunomodulator, immunostimulant, 
nervine tonic and sedative, digestive, laxative, liver tonic, hepatoprotective, 
lymphatic, circulatory stimulant, antiplatelet and others29.    
    
1.4.6 Miscellaneous immunomodulators26: 
 Coloring agents such as cacao pigment, cochineal pigment, corn pigment, 
betanin, carthamus yellow, bixin, curcumin were also found to inhibit IgE 
production by rat spleen lymphocytes. Many of them also decrease IgM and IgG 
at high concentrations. Plant lectins, although too toxic for therapeutic purposes, 
exert a selective mitogenic action on T lymphocyte. They are sugar binding 
carbohydrates-specific proteins or glycoproteins, which agglutinate cells or 
precipitate glyco conjugates. They are of interest because they bind 
predominantly to lymphocytes, where they induce mitosis. Some of them inhibit 
protein synthesis in eukaryotic cells. Some lectins agglutinate malignant cells 
better than normal cells. It was found that even fragments of lectins might be able 
to stimulate lymphocyte, e. g. Phytolacca americana, concanavolin A from 
Canavalia ensiformins, viscumin from Viscum album. Some noted marketed 
products, alleged for as immunomodulators, are 
 Chawanprash awaleha- Dabur, Zandu, Baidyanath 
 Brahmivita granules-Deccan-Ayurvedashram 
 Zandu pancharishta-Zandu 
 Glenseng capsules-Glenmark 
 Revital capsules-Ranbaxy 
 Trinergic capsules-Unichem 
 Immuno cure-Fair pharma 
 IMMU-21 (research name)-contains extracts of Ocimum sanctum and 
Withania  somnifera 
 IM-33 (research name)-contains aqueous extracts of Tinospora 
cordifolia, Withania somnifera, Phyllanthus emblica and Ocimum 
sanctum. 
 Septilin tablets-Himalaya 
Since natural products, especially Indian medicinal plants are the potential 
source of immunomodulatory compounds31, the present study aims at evaluating 
Lagenaria siceraria Molina Standley (cucurbitaceae) fruits for their possible 
immunomodulatory activity.  
 In classical ayurvedic text the fruits of Lagenaria siceraria Molina Standley 
(cucurbitaceae) have been mentioned for such properties as general tonic, 
cardiotonic, aphrodisiac, anti-inflammatory, antileprotic, antirheumatic etc32-33. It 
has also been reported to be used as antiasthmatic and antirheumatic in 
homeopathy34. Further Lagenaria siceraria fruits have been shown to scavenge 
free radicals35. Ribosome inactivating proteins have also been isolated from the 
seeds of this plant36. The plant is also has balancing and rejuvenating effects on 
the three constitutional elements in ayurveda namely vata, pitta and kapha33. 
Cucurbitacin B has also been isolated from Lagenaria siceraria fruits37. 
Cucurbitacin E, isolated from the fruit juice of Ecballium elaterium, has been 
tested for its antihepatotoxic and anti-inflammatory activities and has also been 
reported for its anticancer activity38. Reports also indicate the testing of 
Lagenaria siceraria fruits for their antioxidant, antihyperlipidemic39, antidiabetic40, 
antiulcer41, antibiotic42, analgesics and anti-inflammatory activities43.   
Lagenaria siceraria fruits have been tested for their varied 
pharmacological activities which come under the purview of immunomodulatory 
activity. However there is paucity of data available on the effect of the 
phytoconstituents of Lagenaria siceraria fruits on immune system.  In the 
absence of any scientific evidence for their ability to increase overall resistance 
to the body, an attempt was made to undertake immunologic investigation with 
fruits of Lagenaria siceraria. Further scientifically supported reported claims on 
Lagenaria siceraria fruits prompted us to investigate their possible 
immunomodulatory activity.  
Therefore we decided to extract (and fractionate bioactive extract) fruits of 
Lagenaria siceraria, test them chemically and to test them in experimental 
animals for their possible effect on immune system. Bioactivity guided isolation 
was done to isolate different phytoconstituents which were again tested 
pharmacologically. We report here the immunomodulatory activity of crude 
methanol extract, different fractions of it and isolates by analyzing their effects on 
different pharmacological parameters viz. haemagglutination antibody titre, 
cyclophosphamide-induced myelosuppression, carbon clearance rate (in vivo 
 phagocytosis), delayed type hypersensitivity reaction, hematological parameters. 
The results revealed that Lagenaria siceraria fruits possess promising 
immunomodulatory activity. 
 
 
  
 
 
 
Chapter 2 
Literature 
survey 
 2. Literature survey  
Fossil records date human use of plants as medicines at least to the middle 
Paleolithic age some 60,000 years ago44. Certain of these plants are believed to 
promote positive health and maintain organic resistance against infection by 
reestablishing body equilibrium and conditioning the body tissues15. Modulation 
of immune responses to alleviate disease has been of interest for many years 
and the concept of rasayana in ayurveda is based on related principles45.  Indian 
medicinal plants are rich source of substances that are claimed to induce 
paramunity; the non specific immunomodulation31. 
2.1 Cucurbitaceae 
The cucurbitaceae consists of nearly 100 genera and over 750 species. Although 
most have Old world origins, many species originated in the New world and at 
least 7 genera have origins in both hemispheres. There is a tremendous genetic 
diversity within the family, and the range of adaptation for cucurbit species 
includes tropical and subtropical regions, arid deserts, and temperate locations. 
A few species are adaptable to production at elevations as high as 2000 meters. 
Cucurbits are a well-recognized source of secondary metabolites. Therefore, 
cucurbits are among the largest and the most diverse plant families and are 
cultivated worldwide in a variety of environmental conditions46-47. Cucurbits 
(cucurbitaceae) are among the most important plant families supplying humans 
with edible products and useful fibers. They are associated with the origin of 
agriculture and human civilization and are among the first plant species to be 
domesticated in both Old and New world46. Luffa acutangula, L. cylindrica etc. 
are the examples of the cucurbitaceous plants. From literature survey it is noticed 
that few plants of this family possess ribosome inactivating proteins (such as 
MAP30, Luffin A and B) and terpenes with immunomodulatory48-49, antiretroviral, 
anti HIV50-51, activities besides other pharmacological actions viz. antidiabetic52 
antihyperlipidemic53, antioxidant54 and anticancer55-56.    
Lagenaria siceraria (Molina) Standley (family cucurbitaceae) 
commonly known as lauki (Hindi) and bottle gourd (English) is a medicinal plant 
and utilizable species57. Fruits of this plant are traditionally used for their 
 cardioprotective, cardiotonic, general tonic, aphrodisiac, diuretic and nutritive 
properties33. Fruits are also used in treatment of pain, ulcer, fever, pectoral 
cough, asthma and other bronchial disorders58. Few scientific studies validating 
the folk medicinal uses of Lagenaria siceraria fruits have been reported as 
mentioned ahead. However there is paucity of data available on the effect of the 
extract of Lagenaria siceraria fruits on humoral and cellular immunity in animals. 
Therefore, the present study was undertaken to investigate the 
immunomodulatory effect of Lagenaria siceraria fruits in experimental animals.  
 
2.2 Plant profile   
Name: Lagenaria siceraria (Molina) Standley 
Family: Cucurbitaceae 
A total of six species have been recognized as belonging to the genus Lagenaria. 
One is domesticated monoecious species L. siceraria while five of them are wild 
perennial, dioecious forms from Africa and Madagascar46.  
Lagenaria siceraria is described in ayurveda for its medicinal properties. The 
plant is official in ayurvedic pharmacopoeia of India. The plant Lagenaria 
siceraria is a herb which is a tendril climber and grows throughout the year. The 
plant is with 5-angled hispid stems and 2-feet long tendrils; leaves simple, long-
petioled with two glands at the apex, 5-lobed,cordate,dentate,hairy on both 
surfaces; flowers large, white, solitary, the males long-stalked and the females 
short-stalked32-33,58.  
 
English synonyms: Bottle gourd, calabash, birdhouse, trumpet gourd, and 
white-flowered gourd. The name bottle gourd is especially appropriate, because 
this plant species is one of the few from which useful and lasting containers can 
be made. Cucuzzi is a long club shaped Lagenaria59.   
 
Botanical synonymous  
Cucurbita longa hort., C. siceraria Molina, C. Lagenaria, C. leucantha Duchesne., 
Lagenaria leucantha Rusby, Lagenaria (L.) Cockerell, L. vulgaris Ser60. The word 
 Lagenaria came from lagenos/lagena (Latin) means a flask, cucurbita means 
gourd and vulgaris stands for common and pepo means something like thick 
leathery rind. The species name siceraria probably also refers to the fruit which is 
useful when it is mature and dry (siccus) 61. 
 
Indian synonyms (regional names) (woindia): Hindi:Kaddu, lauki, tumri; 
Bengali:lau; Marathi:bhopala, dudhya; Telgu:sorrakaya; Gujrati:dudhi, tumada; 
Tamil:shorakkai; Kannada:halagumbala, sorekayi; Assami:lau, bogalau; 
Punjabi:ghiya58. Probably no region has as much as diversity and so many 
named varieties of bottle gourd as India59.   
Bottle gourd has been used routinely as a source of rootstock for water 
melon and other cucurbit crops as a means to reduce the incidence of soil-borne 
diseases and to promote the vigor of the root system of crop under conditions of 
low temperature62. This is possible because it possesses excellent tolerance to 
low soil temperature and to soil-borne pathogens like Fusarium oxysporum f. sp. 
Niveum63.   
 
2.3 About bottle gourd fruit 
Bottle gourd fruit is an edible, medicinal, and otherwise utilitarian domesticated 
cucurbit with an ancient pantropical distribution. The bottle gourd has been grown 
worldwide for thousands of years, usually not as a food source, but for the value 
of its strong, hard-shelled, and buoyant fruits, which have long been prized as 
containers, musical instruments, and fishing floats. The dry fruit can float in sea 
water for nearly a year without the seeds loosing viability64-65. Fruits range from 
oblate, spherical, or ovoid to pyriform, dipper-shaped (i.e. an elongated neck at 
the peduncle end), bilobal (i. e. two spheres joined by a constricted neck), club 
shaped (i. e. cylindrical but gradually enlarged towards the blossom end), or 
cylindrical. Although fruit characters are not generally indicative of subspecies, 
plants producing large round fruits are typically native to tropical West Africa, 
whereas the long, thin, snake like fruits are considered to be of Asian origin. 
Warted gourds occur only in Africa and New world65. Young bottle gourd fruits of 
 certain varieties are eaten as a boiled vegetable. The best are slightly sweet, 
tender and free of bitterness. The fruits are often cooked with curries, which 
mask the natural flavors. The carefully selected varieties of India are choice 
vegetables, as good and as nutritious as the popular summer squashes59. The 
mature fruit of bottle gourd is not a highly desirable food as it has little flesh and 
an offensive smell with a bitter taste63. Dried gourds are cleaned painted 
shellacked or waxed. Well treated gourds become durable containers. The dry 
hard shells are used as multipurpose containers (bottles, milk pots, boxes, work 
baskets, water jugs, cups, planters, churns, bowls), utensils (ladles, spoons),  
pipes, floats for fishnets and rafts, carved objects (masks or native artifacts) and 
musical instruments (sitars) 47,59.  
 
2.4 Origin of bottle gourd 
Along with the five wild perennial species that also belong to the genus 
Lagenaria, the bottle gourd has long been recognized as being indigenous to 
Africa. Until the recent discovery and morphological and genetic characterization 
of a wild population of Lagenaria siceraria in Zimbabwe, however, the bottle 
gourd had only ever been adequately documented as a domesticated plant64-65.    
Archaeological remains suggest the independent use and possible cultivation of 
bottle gourd by 9000-15000 B. P.  (before the present) in the Americas, 6000-
10000 B.P., in eastern Asia, and 4000-5000 B. P. in Africa. Indigenous (as 
opposed to naturalized) populations of wild L. siceraria have not been confirmed 
on any continent. Despite this and the lack of early African remains, the origin of 
this species is generally believed to be in Africa. Several issues concerning the 
evolutionary history of bottle gourd remain unresolved. For example neither the 
morphological nor the archaeological data collected to date point to a specific 
region in Africa as the original home of this species. Understanding the 
evolutionary history of L. siceraria is important because of this species‟ unique 
position as one of the earliest cultigens in Africa, Asia and the Americas65.  
 
2.5 Ethno pharmacology (traditional uses of bottle gourd) 
 2.5.1 Bitter fruit variety: The leaves are diuretic, antibilious; useful in 
leucorrhoea, vaginal and uterine complaints, earache. The fruit is bitter, hot, 
pungent, emetic, cooling, cardiotonic, antibilious, cures asthma, bronchitis, 
inflammations, ulcers and pains.  
 
2.5.2 Sweet fruit variety: The stem is sweet, laxative; cures biliouseness; 
causes bronchitis and flatulence. The leaves are laxative. The fruit is sweet, 
oleagenous, cardiotonic, general tonic, aphrodisiac, laxative, cooling, fattening; 
increases vata; improves taste; cures leucorrhoea and biliousness; wholesome to 
fetus. Fruits are tonic to the liver; cures blood diseases of persons with a hot 
constitution; cures muscular pain, and dry cough. The flesh of the fruit is 
considered diuretic, refrigerant. It is also sometimes made into a poultice; when 
fresh, it is bitter and purgative, and is applied over the shaved head in delirium. In 
the Punjab (India), the pulp is applied to the soles, in “burning of the feet” 33. The 
seeds of this plant yield an oil which is used as an application for headache. A 
decoction of plant is employed in the treatment of anasarca, ascites and beriberi. 
The fruit has also anti-swelling effect36.  
 
2.6 Pharmacological studies performed on bottle gourd 
 A water soluble polysaccharide was isolated from a hot aqueous extract 
of the stem bodies of Lagenaria siceraria. The polysaccharide was found 
to be constituted of methyl D-galacturonate, 2-O-methyl-D-xylose and D-
xylose in a ratio of 1:1:166.  
 Fruits were studied for their antioxidant activity and nitric acid(NO) 
scavenging effects in in vitro system. They were also studied for their 
effect on the NO production and NO-induced DNA damage in RAW 
264.7 macrophage. They shown significant antioxidant activity35.          
 In vitro antimicrobial activity was examined for aqueous and alcoholic 
extracts of Lagenaria siceraria fruits. It was evaluated by agar disc 
diffusion method and agar well diffusion method. The six medically 
important bacterial strains chosen were B. cereus, S. aureus, S. 
 epidermidis, K. pneumoniae, A. fecalis, and P. aeruginosa. The results 
were evaluated as the diameter of the inhibition zone of microbial 
growth. Alcoholic extract has been reported to be more effective42.  
 Different fractions of juice obtained by crushing the fresh fruits have 
shown significant antihyperlipidemic activity. The study exhibited that 
elevated levels of blood cholesterol, triglycerides, LDL were significantly 
reduced and decreased HDL level was significantly increased by the 
administration of Lagenaria siceraria fruits39. In another similar study 
fruits have been shown to possess hypolipidemic and antihyperlipidemic 
effects in normocholesterolemic and triton-induced hyperlipidemic rats37.    
 Aqueous extract of seeds yielded lagenin; a ribosome inactivating 
protein (RIP) with a molecular weight of 20kDa. The N-terminal 
sequence of lagenin exhibited a lesser extent of similarity to those of 
other cucurbitaceous RIPs. The deoxyribonucleolytic and ribonucleolytic 
activities of these proteins probably explain their putative role in plants 
as defensive agents against pathogens. The other biological actions of 
RIPs include antiproliferative, antitumor, immunosuppressive, antifertility, 
antiviral and anti-human immunodeficiency virus (anti-HIV) activities. 
The potential applications of RIPs include conjugation with antibodies to 
form immunotoxins for cancer therapy, use as anti HIV agents in AIDS 
therapy and expression in transgenic plants to increase their resistance 
against viral and fungal infections36.                  
 The antihepatotoxic activity of different fractions of the ethanolic extract 
of Lagenaria siceraria fruit, administered orally to different groups of rats, 
was evaluated using CCL4-induced hepatotoxicity test. All the fractions 
tested, in a dose of 250 mg/kg, showed significant activity, with 
petroleum ether fraction exhibiting comparatively higher activity. Two 
steroids were isolated from petroleum ether fraction and they were 
identified as fucosterol and campesterol67.    
 Many plants belonging to cucurbitaceae family are known to possess 
anthelmintic activity. The anthelmintic efficacy of Lagenaria siceraria 
 seeds, against Hymenolepis nana (tapeworm) and Aspicularis tetraptera 
(pinworm) infections in mice was evaluated utilizing piperazine citrate as 
a reference substance for comparison. The ethanolic extract of seeds 
exhibited a potent activity against tapeworm68.  
 Vacuum dried juice extract and methanol extract of the fruits have been 
evaluated for their diuretic activity in albino rats. Different parameters viz. 
total urine volume (corrected for water intake during the test period), 
urine concentration of electrolyte such as sodium, potassium and 
chloride have been evaluated. The rats treated with juice and extract 
(100-200 mg/kg; p.o.) showed higher urine volume when compared with 
respective control. Both juice and extract exhibited dose-dependent 
increases in the excretion of electrolyte when compared with control 
group69.       
 The analgesic effect of Lagenaria siceraria fruit juice extract was 
evaluated using acetic acid-induced writhing and formalin pain tests in 
mice. For investigating anti-inflammatory activity, four different animal 
models (ethyl phenylpropionate-induced ear edema, carrageenin and 
arachidonic acid-induced hind paw edema and also the albumin-induced 
paw edema in rats) were employed. Juice has shown significant 
analgesic and anti-inflammatory effects. The possible role of flavonoids 
and saponins in the said activities has been indicated in this study43.   
 Fruits have been tested for antiulcer activity. Petroleum ether, 
chloroform, alcoholic extracts were evaluated in rats. Petroleum ether 
extract showed better antiulcer activity. It increased serum calcium level 
and decreased serum alkaline phosphatase level. It also decreased free 
acidity, total acidity and in total volume of gastric contents41.    
 
2.7 Chemical constituents isolated/detected in bottle gourd 
 Lauki is one of the excellent fruits for human being made and gifted by 
nature having composition of all the essential constituents that are 
 required for normal and good health70. Earlier researchers have reported 
different classes of chemicals in the fruits of Lagenaria siceraria.  
 Bitter fruits yield 0.013 % of a solid foam containing cucurbitacins B, D, G 
and H mainly cucurbitacin B (C32H48O8); these bitter principles are present 
in the fruit as aglycone. Leaves contain cucurbitacin B, and roots, 
cucurbitacin B, D and traces of E. Cucurbitacin is associated with the co-
evolution of cucumber beetle. It is a toxic secondary compound. It is a 
tetracyclic terpenoids that arose to protect the plant from herbivores, 
functioning as repellent for most insect species.). The fruit juice contains 
glycosidase (elaterase). Plants which yield non-bitter fruits contain no 
bitter principles or elaterase46,58.  
 Fruits are reported to contain more soluble dietary fibers than insoluble 
cellulose fibers37.  
 The fruits are considered as good source of vitamin C, β-carotene, vitamin 
B-complex, pectin and also contain highest choline level- a lipoprotic 
factor60.  
 Phytochemical investigation of the petroleum ether extract revealed the 
presence of oils (8.6%), proteins (38.7%), and carbohydrates (5.2%). The 
oil found to contain palmitic acid (42.41%), oleic acid (9.67%), stearic acid 
(6.7%), valine (10.3%), histidine (1.48%), methionine and cystine (1.6%), 
and tryptophan (0.2%). Sugars present were four monorhamnose (4%), 
fructose (12.8%), raffnose (9.3%) and stachyose (8.5%)41.   
 The fruits were also found to contain cucurbitacins BDGH and 22 deoxy 
cucurbitacin .Fruit juice contains beta glycosidase elaterase enzyme60.  
 Palmitic acid, steric acid, oleic acid and linoleic acid were identified in 
seed oil71.  
 Palmitic acid, palmitoleic acid, steric acid, oleic acid and linoleic acid have 
been isolated from seed oil. Rhamnose, fructose, glucose, galactose, 
sucrose, raffinose and stachyose were also isolated from seeds72.  
 Two triterpenoids-22-deoxycucurbitacins D and 22-deoxycucurbitacin D 
were isolated from fruits73.  
  Avenasterol, codisterol, clerosterol, isofucosterol, stigmasterol, 
campesterol, spinosterol, 25(27)-dehydroporiferasterol, 25(27)-
dehydrofungisterol, 25(27) –dehydrochondrillasterol, 24β –ethyl – 25 (27) 
–dehdrolathosterol, 24 –methyllathosterol and 22- dihydrospinasterol were 
identified in seeds74. 
 7-O- glucosyl-6-C glucoside apigenin, 6-C-glucoside apigenin, 6-C 
glucoside luteolin, 7, 4‟-O-diglucosyl -6-C-glucoside apigenin57 and 
saponarin 4‟-O-glucoside34 have been isolated from the Lagenaria 
siceraria (flowering herb). Kaempferol and quercetin 3-O-rutinosides were 
also found in the pollen of Lagenaria siceraria57. 
Thus the review of literature suggests that terpenoids, saponins, flavonoids and 
polysaccharides are there in Lagenaria siceraria fruits and other plants of 
cucurbitaceae family and these primary and secondary plant metabolites 
(isolated from variety of plants) have shown immunomodulatory activity. Further it 
has been reported that higher plants, with low molecular weight compounds like; 
alkaloids, quinones, flavonoids, vitamin C, caretenoids and terpenoids and high 
molecular weight compounds like; polysaccharides and glycoproteoins have 
pronounced immunomodulatory potential20. Recently it has been observed that 
Lagenaria siceraria fruits are being recommended for atherosclerosis treatment 
and other ailments as mentioned earlier75-76. This has prompted us to extract and 
fractionate pharmacologically active phytoconstituents from fruits of Lagenaria 
siceraria.  
2.8 Investigation of potential immunomodulating compounds 
In developing useful immunomodulators, a successful compound should meet 
several criterions that have been laid down by the WHO (1976). A suitable 
immunomodulatory compound should be: 
 Chemically well defined 
Easily biodegradable  
 Non carcinogenic and non mutagenic 
Non toxic and without any side or cascade effects 
Neither too strong nor to weak in its modulatory efficacy4 
 In the search for plant constituents with immunostimulating potency one can 
select those plant drugs which so far have been used in traditional medicine. In 
the old literature one will not find the term immunostimulation/immunomodulation. 
One can assume, however, that many plants described for their antibacterial, 
antiviral, antifungal or antitumoral activities are good candidates for screening20.       
Immunomodulatory agents of plant origin increase the immune 
responsiveness of the body against pathogens by activating primarily the non-
specific immune system i. e. stimulation of the function and efficiency of the 
granulocytes, macrophages and complement etc. However these drugs should 
be subjected to systematic studies to substantiate the therapeutic claims with 
regard to their clinical utility77. For the screening of plant constituents, those in 
vitro and in vivo test systems are appropriate which allow the determination of 
the functional state and the efficiency of the cellular and humoral unspecific 
immune system, in particular those which include granulocytes, macrophages, T 
lymphocyte populations, NK cells and the complement as target cells or systems. 
In addition to that, infectious stress (cytotoxicity) tests with e. g. Candida 
albicans, Staphylococcus spp., Listeria enriettii in mice or the tumor 
transplantation inhibition test are also performed. In recent years the flow 
cytometric methods have brought great methodological progress, especially for 
monitoring the immune status of a patient during immune therapy20. The study of 
development and function of the immune system in vitro and in vivo has made 
intensive use of animal models. During the last decades, there have been 
constant efforts to design animal models permitting an in vivo approach of the 
human immune system. Confronted with the exploding HIV pandemic in the 
1980s, the need for a small easy-to-handle animal model of human lymphocyte 
development arose78. 
 A great number of in vitro and in vivo test systems are available today, 
which allow plant drugs or phytoconstituents to be selected and screened for 
potentially immunological activities. Considering the variety of cellular and 
humoral functions of the immune system and the condition-dependent effects of 
immunomodulatory agents, it is unlikely a single test system will be satisfactory 
 for screening and/or characterization of new immunomodulatory agents. The final 
choice of model depends upon the characteristics of the agent under 
development and the therapeutic target. The various methods available for 
screening immunomodulatory agents are4,31:  
 In vitro phagocytosis 
Phagocytic index 
Chemiluminescence test  
Bioluminescence test 
 Macrophage migration inhibition test 
 Immune induced cytotoxicity tests  
 Lymphocyte transformation test and its modifications 
 Haemagglutination antibody (HA) titre (humoral immunity) 
 Delayed type hypersensitivity(DTH) reaction test/(CMI-cell mediated 
immunity)/ Type IV hypersensitivity reaction 
 Flow cytometric assay  
 Lymphocyte proliferation assay 
 Assay of natural killer (NK) cell activity  
 Assay of TNF (tissue necrosis factor) production   
 Assay for complement active compounds (anti-inflammatory agents)  
 E. Coli induced abdominal peritonitis (Evaluation of 
immunoprophylactic   effect)  
 Plaque forming cell assay  
 Determination of nitric acid)  
 Adaptogenic activity)  
o Endurance test 
o Five hour swimming test 
o Restraint ulcers  
o Carbon tetrachloride induced hepatotoxicity 
o Effect of stress on humoral response     
Among all these tests, DTH reaction and HT titre tests are among the oldest 
surviving tests for the testing of immunomodulatory tests. In a recent report, 
 researchers have used pyrogallol as a novel tool for screening potential 
immunomodulators in rats17. It is a strong generator of free radicals and it is 
reported that it can suppress the proliferation of mouse lymphocytes in in vitro. It 
has been concluded that pyrogallol-induced immunosuppression is related to 
oxidative stress.    
In clinical practice a wide variety of techniques have been used to test 
immunologic competence and its drug-induced alteration .The simplest tests that 
can be used to determine effects of immunosuppressive or immunostimulating 
agents include the following. Many of them are available through the pathology 
departments of major medical centers79. 
I. Delayed- type hypersensitivity reaction testing with skin test antigens to 
detect the ability to respond to recall antigens, including antigens derived 
from common microbial pathogens such as Candida. The Merieux skin 
test device is an approach to skin testing. 
II. Measurement of serum immunoglobulins, serum complement and specific 
antibodies to various natural and acquired antigens. 
III. Serial measurements of antibody response after primary immunization or 
a secondary booster injection. 
IV. Total circulating lymphocyte count. 
V. Measurement of the percentages of B cells, T cells, and subsets such as 
CD4, CD8, CD11a and CD56 (for example monoclonal antibodies) that 
comprise the circulating blood lymphocyte count. 
VI. In vitro lymphocyte proliferative responses to mitogens such as 
phytohemagglutinin, concanavalin A and pokeweed mitogens or to 
specific antigens of interest. The response may be measured by tritiated 
thymidine incorporation or by cytokine production (INF-γ, IL-2, TNF and 
others). 
VII. Mixed lymphocyte reaction, in which the lymphocyte of one individual are 
mixed with and proliferate in response to allogenic lymphocytes of another 
individual. 
VIII. NK cell cytotoxicity to target tumor cells. 
 Other assays that are not standard but may be useful in a clinical research 
setting include 
a) Measurement of intracellular cytokines in circulating lymphocytes  
b) Measurement of lymphocyte surface zeta chains  
c) Measurement of lymphocyte signal transduction and 
d) Measurement of T cell-mediated cytotoxicity. 
Screening with a battery of in vivo and in vitro assays allows the detection of 
selective action of candidate drug, already in an early stage. On the basis of 
activity found in the screen test, an action-guided fractionation and purification of 
crude extracts is conducted until one or more single active compounds have 
been isolated. After the identification and the structural elucidation of the active 
compounds the mechanism of action is studied. In this stage attention is given to 
the question of specificity, selectivity and toxicity4.  
Recently phytopharmaceutical research received much attention to 
develop safe and effective lead compound/fraction with potential 
immunomodulatory activity. The present study was therefore planned to 
fractionate drug from medicinal plant (Lagenaria siceraria) with minimum side 
effects and toxicity as compare to synthetic drugs that may offer 
immunostimulant or immunosuppressant action. Both these effects have 
significant role in the management of various diseases e. g. immunostimulants 
will be helpful in the prophylaxis and treatment of some immuno-compromised 
diseases such as AIDS etc. and against infectious diseases. Whereas 
immunosuppressants would show potential in combating autoimmune diseases 
such as systemic lupus erythematosus, myasthenia gravis as well as 
hypersensitivity reactions, graft rejection etc.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Objective 
 3. Objective  
It has been reported that higher plants, with low molecular weight compounds 
like; alkaloids, quinones, flavonoids, vitamin C, caretenoids and terpenoids and 
high molecular weight compounds like; polysaccharides and glycoproteoins have 
pronounced immunomodulatory potential20.  
 The review of literature suggests that terpenoids, saponins, flavonoids 
and polysaccharides are there in Lagenaria siceraria fruits and other plants of 
cucurbitaceae family and these primary and secondary plant metabolites 
extracted from other medicinal plants have shown immunomodulatory activity. 
Recently it has been observed that Lagenaria siceraria fruits are being 
recommended for treatment of atherosclerosis and other ailments. Besides these 
scientifically supported claims; fruits have also been mentioned in ayurveda for 
their uses as general tonic, cardiotonic, aphrodisiac, anti-inflammatory, 
antileprotic, antirheumatic and other activities. However there is paucity of data 
available on the effect of the phytoconstituents of Lagenaria siceraria fruit on 
immune system.   
 In the absence of any scientific evidence for their ability to increase 
overall resistance to the body, an attempt was made to undertake immunologic 
investigation with fruits of Lagenaria siceraria. With this aim, present research 
work deals with the extraction of Lagenaria siceraria fruits with different organic 
solvents using Soxhlet apparatus. Further bioactive extract was fractionated with 
other organic solvents to enrich it in specific secondary metabolites. Finally there 
is reporting of bioactivity guided isolation of phytoconstituents of Lagenaria 
siceraria fruits. All these extracts, fractions and few isolates were tested in 
experimental animals to investigate their possible effect on immune system using 
variety of parameters. Isolates were identified using various spectroscopic 
methods.  
          
 
   
 
 
 
 
 
 
Chapter 4 
Materials 
and 
methods 
 4. Materials and methods 
4.1 Collection, identification and authentication of plant material  
The plant material was collected from outfield of Junagadh city, Gujarat state, 
India in March 2007. Plant was authenticated by the authority of department of 
botany, Bahauddin college, Junagadh, where a voucher specimen (BS/Bot./I-
5/06-07)has been deposited for future reference.     
  
 Fig.: 2 Authenticated herbarium of bottle gourd 
 
 4.2 Chemicals 
Pelican ink 4001, Germany (colloidal carbon), obtained from shoppers shop, 
Madurai, India. Cyclophosphamide (Dabur, India) was used as a standard 
immunomodulatory agent. All the reagents were of analytical grade. Thin layer 
chromatography plates were of E. Merck (silica gel G 60 F254 layer thickness 
0.2mm). 
 
4.3 Extraction   
Dried powdered fruits of Lagenaria siceraria (500 gm) were defatted with 
petroleum ether (60-800) and then extracted with methanol in a soxhlet 
apparatus. Extraction was done with each solvent until the supernatant in the 
soxhlet became transparent (approximately 30 hours). Methanol extract was then 
filtered, concentrated by distilling off the solvents and evaporated to dryness 
using water bath to get crude methanol extract (CME). CME was tested in 
experimental animals for its possible effect on immune system. It was also tested 
phytochemically.   
 
4.4 Immunomodulatory activity of CME 
4.4.1 Experimental animals 
Wistar albino rats of either sex and weighing 150 to 200 gm were housed in 
groups of four per cage under controlled light (12:12 light: dark cycle) and 
temperature (25 ± 20C) environment and behavioral assessment was conducted 
during the light cycle. Food (Pranav agro sales, Ahmedabad) and water was 
provided ad libitum. All procedures were carried out under strict compliance with 
ethical principles and guidelines of the Institutional Animal Ethical Committee 
constituted as per the direction of the Committee for the Purpose of Control and 
Supervision of Experimental Animals, Madras.  
 
 4.4.2 Acute toxicity studies 
Over night fasted rats were used for the study. CME was administered orally (in 
1% sodium carboxy methyl cellulose, SCMC) to different groups (each of five 
animals) in increasing dose levels of 125, 250, 500, 1000 and 2000 mg/kg body 
weight. Animals were observed continuously for 1 hour, then frequently for 24 
hours thereafter once daily for 14 days. During this period; animals were 
observed for gross behavioral and morphological changes. During this 
observation no toxic symptoms were seen. All the animals survived the toxicity 
studies at all dose levels. Based on the study; doses of 100,200 and 500 mg/kg 
body weight were selected for animal experiments.  
 
4.4.3 Preparation of the test extract 
CME was suspended in 1% SCMC in distilled water to prepare different doses 
(100, 200 and 500 mg/kg body weight) and administered orally with the help of 
gastric canula. The control animals were given an equivalent volume of SCMC 
vehicle. Cyclophosphamide was used as a standard immunosuppressant. 
 
4.4.4 Antigen 
Fresh blood was collected from sheep sacrificed in local slaughter house in 
Alsever‟s solution (formula is mentioned ahead). During the experiment, 
adequate amount of stock solution (sheep red blood cells, SRBC, stored in 
Alsever‟s solution) was taken and allowed to stand at room temperature. It was 
washed three times with normal saline. The settled SRBC was then suspended 
in normal saline and RBC of this suspension was adjusted to a concentration of 
5×109 /ml for immunization and challenge80. 
 
 4.4.5 Preparation of Alsever’s solution81  
Formula: 
Citric acid                                                                    0.055gm 
Sodium citrate                                                             0.8gm 
Glucose                                                                       2.05gm 
Sodium chloride                                                          0.42gm 
Distilled water to make volume up to                          100 ml 
 
All the above solids were weighed and dissolved in distilled water in a conical 
flask and made the volume up to 100 ml. It was then stored in refrigerator. 
 
4.4.6 Blood withdrawal 
For withdrawing the blood samples, the animals were lightly anaesthetized using 
ethyl ether. A fine capillary was gently inserted into the lower angle of eye at 45o 
and blood was withdrawn from retro orbital plexus into micro centrifuge tubes. 
 
4.5 Immunomodulatory protocols 
4.5.1 SRBC–induced humoral antibody (HA) titre 
The method described by Atal et al45. was followed. Groups of six rats per 
treatment were immunized by injecting 20 µl of SRBC suspension (5×109 SRBC 
/ml) subcutaneously into right hind foot pad. Seven days later they were 
challenged by injecting 20 µl of SRBC suspension (5×109SRBC /ml) 
intradermally into the left hind foot pad. The day of immunization was referred to 
as day 0. Blood samples were collected from all the animals separately by retro 
orbital puncture on day +7 (before challenge) for primary antibody titre and on 
day +14 for secondary antibody tire. Antibody levels were determined by the 
method described by Shinde et al82. Briefly 25 µl aliquot of serum of each animal 
was taken in microtitre plates. To serial two –fold dilutions of pooled serum 
(made in 25 µl normal saline), 25 µl of 1% v/v SRBC suspension (in normal 
saline) was added. The microtitre plates were kept at room temperature for 1 
 hour and then observed for haemagglutination (until control wells showed 
unequivocally negative pattern).The value of the highest serum dilution showing 
haemagglutination was taken as the antibody titre. CME was fed orally once 
daily, starting with 7 days prior to sensitization till the challenge (-7,-6,-5,-4,-3,-2,-
1,0,+1,+2,+3,+4,+5,+6,+7). 
 
25µl of serum + 25µl of normal saline                                  50 µl of 2 fold dilution 
25µl of 2 fold dilution+ 25µl of normal saline                   50 µl of 4 fold dilution 
25µl of 4 fold dilution+ 25µl of normal saline                        50 µl of 8 fold dilution 
                                         Continued to get higher dilution (up to 12 wells). 
After this in each well, 25µl of 1 %( v/v) SRBC suspension in saline was added. 
 
4.5.2 In vivo phagocytosis83 
Animals of the treatment group were given CME daily for 5 days. At the end of 
five days, after 48 hours, rats were injected via tail vein with carbon ink 
suspension (10 µl /gm body weight).Blood samples were drawn (in EDTA 
solution, 5 µl) from the retro orbital vein at 0 and 15 minutes.; a 25 µl sample was 
mixed with 0.1% sodium carbonate solution (2 ml) and its optical density was 
measured at 680 nm. The phagocytic index (K) was calculated using the 
equation: K= (logOD1-logOD2)/ 15 where OD1 and OD2   are optical densities at 0 
and 15 minutes respectively.  
 
4.5.3 Cyclophosphamide-induced myelosuppression84 
Animals were divided into five groups each of six. Group I (control group) and 
group II (cyclophosphamide treated control) received the vehicle for a period of 
13 days. Groups III-V were given CME daily for 13 days. The animals of group II-
V were injected with cyclophosphamide (30 mg/kg, i.p.) on the 11th, 12th and 13th 
day; 1 hour after the administration of the respective treatment. Blood samples 
were collected on the day 0 and on the day 14 and total white blood cell (WBC) 
count was determined by using a haemocytometer. 
 
 4.6 Successive solvent extraction 
Another batch of powdered dried fruits (2000 gm) was successively extracted 
with petroleum ether (60-800), dichloromethane, chloroform and methanol using 
a soxhlet apparatus. Extraction was done with each solvent until the supernatant 
in the soxhlet became transparent (approximately 30 hours).  Before taking the 
solvents of higher polarity, to remove the traces of previous solvents, exhausted 
marc was completely dried. All the extracts were filtered, dried and weighed. 
Successive methanol extract (SME) was then suspended in water and 
fractionated with ethyl acetate (3×300ml) and then n butanol (3×300ml) in a 
separatory funnel to enrich methanol extract into flavonoids and saponins 
respectively. All these extracts and fractions were then tested for their 
immunomodulatory activity in experimental animals. Bioactive fractions were 
tested phytochemically and submitted to column chromatography to separate the 
phytoconstituents.  
 
4.7 Immunomodulatory activity of successive extracts and fractions of SME 
Experimental animals, acute toxicity study, preparation of test extracts and 
antigen were same as mentioned earlier.  
 
4.8 Immunomodulatory protocols  
4.8.1 SRBC –induced delayed type hypersensitivity reaction 
Delayed type hypersensitivity (DTH) reaction was induced in rats by the method 
of Doherty 2. Groups of six rats per treatment were immunized by injecting 20 µl 
of SRBC suspension (5×109 SRBC/ml) subcutaneously into the right hind foot 
pad of each rat. The day of sensitization was designated day 0. Seven days later, 
the thickness of the left hind foot pad was measured using a vernier caliper 
reading to 0.01 mm. The rats were then challenged by injecting 20 µl of SRBC 
suspension (5×109 SRBC/ml) intradermally into the left hind foot pad. Foot pad 
thickness was again measured after 24 and 48 hours of challenge. The 
difference between the pre and post challenge foot pad thickness (expressed in 
mm) was taken as a measure of DTH reaction and results were expressed as 
 percent change in thickness. Both fractions of extract were fed orally once daily, 
starting with 7 days prior to sensitization till the challenge (-7,-6,-5,-4,-3,-2,-
+1,0,+1,+2,+3,+4,+5,+6,+7). 
 
4.8.2 SRB –induced humoral antibody (HA) titre 
The method described in 4.5.1 was followed here.  
 
 4.8.3 Haematological profile 
After eight days of administration of the fractions, blood was collected from retro 
orbital plexus of each animal. Various parameters such as total white blood cell 
(WBC) count (by haemocytometer) and differential count (by Leishman‟s stain) 
were determined as mentioned under6:  
 
Total leukocyte count (TLC)  
Blood sample was withdrawn and diluted with Turk‟s fluid in WBC pipette, in 
which red blood cells were lysed without affecting the leukocyte population. The 
counting was done using Neubauer‟s chamber12. 
 
Differential leukocyte count (DLC) 
Blood smear was made on a clean glass slide and stained with Leishman„s stain. 
Among the hundred leukocytes counted, different types of leukocytes were 
observed and identified based on the cell size, presence of granules, size and 
color of granules and shape of the nucleus under an oil immersion preparation. 
The results of these counts were compared with animals of the control group 
which were only given vehicle using a similar procedure to that performed in the 
test groups12. 
 
4.9 Phytochemical screening of pharmacologically active extract/fractions  
4.9.1 Qualitative chemical test 
Biologically active extract and fractions (i. e. CME and different fractions of SME) 
were chemically tested to know the presence of different primary and secondary 
metabolites present in them as per the following scheme85-87: 
 
Tests for sterol/steroids 
Salkowaski test 
Few mg of the sample was taken in 2 ml of chloroform and 2 ml of concentrated 
sulphuric acid and shaken. The development of red color in the chloroform layer 
indicates the presence of sterols/steroids. 
 Test for terpenoids 
Liebermann –Burchard test  
Few mg of the sample was dissolved in 1 ml of chloroform and few drops of 
acetic anhydride. Concentrated sulphuric acid was added by the side of the test 
tube. Production of purple color indicates the presence of triterpenoids and blue 
–green color indicates the presence of sterols. 
 
Test for alkaloids 
Few mg of the sample was taken in 5 ml of 1.5% v/v hydrochloric acid and 
filtered.  The filtrate was then tested using following reagents:  
Dragendorff’s reagent  
It is a solution of potassium bismuth iodide. It was prepared by dissolving 
bismuth nitrate (8 gm) in nitric acid (20ml) and separately dissolving potassium 
iodide (27.2 gm) in water (50ml), mixing the two solutions and making up the 
volume to 100 ml. Above Dragendorff‟s reagent was sprayed on Whatman No. 1 
filter paper then the paper was dried. The test filtrate after basification with dilute 
ammonia was extracted with chloroform and the chloroform extract was applied 
on the filter paper, impregnated with Dragendorff‟s reagent, with the help of a 
capillary tube.  Development of an orange red color on the paper indicated the 
presence of alkaloids. 
 
Mayer’s Reagent  
1.36 gm of mercuric chloride and 3 gm of potassium iodide were dissolved in 
water to make 100 ml. To a little of each extract taken in dilute hydrochloric acid 
in a watch glass ,few drops of   the reagent was added ,formation of cream 
colored  precipitate shows  the presence of alkaloid. 
Hager’s reagent 
It is a saturated solution of picric acid in water. When the test filtrate was treated 
with this reagent, yellow precipitate was obtained indicating the presence of 
alkaloids. 
 
 Wagner’s Reagent 
It is a solution of potassium triiodide in water which was prepared by dissolving 
1.3 gm iodine in a solution of potassium iodide (2 gm) in water to make 100 ml. 
Formation of brown precipitate after addition of this reagent in extract indicates 
the presence of alkaloids. 
 
Test for tannins  
Sample was taken separately in water, warmed and filtered.  Tests were carried 
out with the filtrate using following reagents: 
 
Ferric chloride test 
A 5% w/v solution of ferric chloride in 90% alcohol was prepared.  Few drops of 
this solution were added to a little of the above filtrate. Dark green or deep blue 
color shows the presence of tannins. 
 
Lead acetate test 
A 10% w/v solution of basic lead acetate in distilled water was added to the test 
filtrate.  Precipitate indicates the presence of tannins. 
 
Test for flavonoids  
 
Shinoda test  
To the sample, 5 ml of 95% ethanol, few drops of HCl and few magnesium 
turnings were added. The pink color shows the presence of flavonoids. 
 
Test for carbohydrates 
Molisch's test 
About 0.1 gm of the sample was dissolved in 2 ml of water and added 2-3 drops 
of 1 % ethanolic solution of alpha napthol and then carefully poured 2 ml of 
concentrated sulphuric acid down the side of the test tube so that it forms a 
 heavy layer at the bottom. A deep violet color is produced if carbohydrates are 
present.  
 
Fehling‘s test 
1 ml of Fehling‟s A and 1 ml of Fehling‟s B solutions were mixed and boiled for 1 
minute. Equal volume of sample was then added, heated in boiling water bath for 
5-10 minutes. First a yellow then brick red color shows the presence of 
carbohydrates. 
 
Benedict’s test 
Equal volumes of the reagent and sample were added. Mixture was then boiled 
for five minutes. Depending on the reducing sugar present a range of colors 
develops.    
  
Test for proteins 
Biuret test 
To the sample 4% NaOH and few drops of 1% CuSO4 were added. Violet or pink 
color indicates the presence of proteins. 
Xanthoproteic test 
Sample was mixed with 1 ml of concentrated sulphuric acid, formation of 
precipitate shows positive test.  
 
Millon‘s test 
3 ml of sample was mixed with Millon„s reagent, formation of precipitate indicates 
the presence of proteins.  
 
Test for saponins 
Foam test 
A few mg of the sample was shaken vigorously with water. Honeycomb like foam 
indicates the presence of saponins. 
 
 Heamolytic test  
Sample was added to one drop of blood placed on glass slide. Hemolytic zone 
indicated the presence of saponins. 
 
Test for anthraquinone glycosides 
Borntrager’s test 
To 3 ml of the sample, dilute sulphuric acid was added, boiled and flittered. To 
the filtrate equal volume of chloroform was added and shaken. After separating 
the organic layer, ammonia was added. Turning pink of ammonical layer 
indicates the presence of said glycosides. 
 
Test for cardiac glycosides  
Keller-Kiliani test 
The sample was dissolved in acetic acid containing trace amounts of ferric 
chloride. It was then transferred to the surface of concentrated sulphuric acid. A 
reddish brown ring will be formed at the junction and the color slowly changes to 
blue. 
Legal test 
A few drops of pyridine and sodium nitroprusside were added to the sample and 
made alkaline. A pink or red color is obtained.   
 
4.9.2 Chromatography study  
4.9.2.1 Thin layer chromatography (TLC)  
Chromatography chambers, conditions of saturation and the development 
of TLC plates:  
TLC study was done for bioactive n butanol and ethyl acetate fractions to find out 
the probable number of compounds present in them. On the pre coated TLC 
plate, test samples (after dissolving in respective solvents) were applied in the 
form of spots with the help of fine capillary. Spots were marked on the top of the 
plate for their identification. Rectangular glass chambers were used for 
chromatography. To avoid insufficient chamber saturation and undesirable edge 
 effect, a smooth sheet of filter paper was placed (in U shape) in TLC chamber 
and was allowed to be in the developing solvent. Having been moistened, the 
paper was then pressed against the walls of the chamber, so that it adhered to 
the walls. A number of developing solvent systems were tried during the study. 
Each time plate was sprayed with vanillin sulphuric acid and heated at 1000C for 
5 minutes. The most informative and satisfactory resolution was taken as final 
solvent system. Solvent systems; n butanol: acetic acid: water (4:1:5) and 
chloroform: methanol (90:10) were found to be most appropriate for ethyl acetate 
and n butanol fractions respectively. Ethyl acetate spotted plate was sprayed with 
anisaldehyde sulphuric acid and heated at 1100C for 5 minutes. Plate was also 
treated separately with 1% AlCl3 in methanol and observed under UV light. After 
development of plates, they were air-dried and number of spots, color and Rf 
values were recorded. 
 
4.9.2.2 High performance thin layer chromatography (HPTLC)  
CAMAG HPTLC system consisting of following features was used: 
 CAMAG automatic TLC sampler 4 (ATS4) 
 CAMAG TLC scanner III (densitometer)with CAT 4 version software for 
scanning and documentation 
 CAMAG high tech UV cabinet fitted with dual wavelength 254/366 nm,8W 
UV  lamp used for inspection of TLC plates. 
 Twin trough glass chambers with stainless steel lids were used for 
chromatographic development. 
 
4.9.2.2.1 Development of chromatogram of n butanol extract 
HPTLC fingerprint profile was established for n butanol soluble fractions of SME. 
TLC plate was washed with methanol by ascending mode, dried and activated at 
1200C for 1 hour prior to application of sample bands. The sample was dissolved 
in 10 ml of n butanol, sonicated for 10 minutes, filtered and applied on TLC plates 
(5×10 cm) in 2 tracks (10 μl and 20 μl) in the form of band. One side of twin 
trough camber was charged with the solvent system chloroform: methanol 
 (90:10) and allowed to equilibrate for 10 minutes. The spotted plate was then 
dipped in mobile phase and solvent front was allowed to travel about 70-80% 
distance on the plate vertically. Plate was then removed from chamber and dried.  
Plate was then scanned at 290 nm and then sprayed with vanillin 
sulphuric acid and heated at 1000C for 5 minutes and then again scanned at 580 
nm. Photos of the plate were taken at 254 nm and 366nm before derivatization 
with detecting agent and at 366 nm and at visible range after derivatization. 
Number of spots, color, Rf values and % relative areas were recorded. 
 
4.9.2.2.2 Development of chromatogram of ethyl acetate soluble fraction 
Except mobile phase and detecting agents all the conditions were kept same as 
mentioned above. The sample was dissolved in 10 ml of methanol, sonicated for 
10 minutes, filtered and applied on TLC plates in 5 tracks (20 μl, 15 μl, 10 μl, 5 μl 
and 2 μl). The mobile phase was n butanol: acetic acid: water (4:1:5). The 
spotted plate was then dipped in mobile phase and solvent front was allowed to 
travel about 70-80% distance on the plate vertically.  
Plate was then removed from chamber and dried. It was then scanned at 
290 nm and then sprayed with anisaldehyde sulphuric acid and heated at 1100C 
for 5 minutes and then again scanned at 600 nm. Photos were taken at 254 nm 
and 366nm before derivatization with detecting agent and at 366 nm and at 
visible range after derivatization. Plate was also treated separately with 1 % AlCl3 
in methanol for ethyl acetate soluble fraction, and observed under UV light. 
Number of spots, color, Rf values and % relative areas were recorded. 
 
4.10 Bioactivity guided isolation of phytoconstituents  
4.10.1 Preparation of the column 
Glass column was packed by wet filling. The slurry of adsorbent (silica gel; 60-
120 mesh) was prepared by mixing the adsorbent in the methanol and used as 
stationary phase. It was then poured into glass column (60cm x 4.5cm) (having 
sintered glass disc at its bottom) and allowed to settle. The air entrapped was 
removed by stirring with glass rod. A small amount of sand was kept atop the 
 column to provide the latter a flat base.  Excess of solvent was run off until the 
level of mobile phase fell to one cm just above the top of the sand layer. 
 
4.10.2 Preparation of sample and loading 
n butanol fraction (5g) was dissolved in a minimum volume of methanol, 
adsorbed on silica gel (60-120 mesh), dried and applied on the column to 
separate possible phytoconstituents. 
 
4.10.3 Selection of mobile phase and separation of the constituents 
The combinations of solvent systems developed for TLC (and HPTLC) were used 
as mobile phase for column chromatography. Alteration in the composition of the 
eluting solvent was achieved by adding the second solvent of more polarity 
gradually to a reservoir of the first. Column was first eluted with methanol to give 
a crude saponin that showed many spots on silica gel TLC plate with chloroform: 
methanol (09:01).This mixture was again subjected to column chromatography 
eluting with chloroform, chloroform-methanol mixtures 95:5, 90:10, 80:20, 50:50 
and methanol. Mobile phase was passed with constant flow rate (5ml/min). At 
uniform interval, the elutes (each of five ml) were collected and the progress of 
separation was monitored by thin layer chromatography using solvent system 
chloroform: methanol (90:10) and iodine vapor as detecting agent. 
Fractions eluted with chloroform: methanol (95:5) and 18-25 fraction of 
chloroform: methanol (90:10), which showed single spot on TLC, designated as 
compound I (17% w/w, 0.85 gm). Fraction 26-39 eluted with chloroform: 
methanol (90:10) afforded a mixture (22% w/w, 1.1gm) of compound II and III as 
mentioned in Table 5. Those fractions which were eluted in considerable 
quantities and in pure form (after evaporating the respective mobile phase) were 
characterized after recrystallization from methanol. 
The same procedure was followed for ethyl acetate soluble part of SME 
using chloroform, chloroform: ethyl acetate (50:50), ethyl acetate, ethyl acetate: 
methanol (90:10) and methanol to give compound VI (12% w/w, 0.6 gm) and VII 
(5.5% w/w, 0.275 gm) as mentioned in Table 6. These compounds had shown 
 single spot on TLC plate where the chromatograms were developed in n butanol: 
acetic acid: water (4:1:5) and the plates were sprayed with anisaldehyde 
sulphuric acid and heated for 5 minutes at 110oc. These compounds were 
purified by recrystallization from methanol. Total five compounds (I, mixture of II 
and III, VI and VII) were isolated in significant quantities and their 
characterization was done using different spectral techniques (1H-NMR, 13C-
NMR, IR and UV analyses) to reveal their identity. 
 
 
 Table 5: Separation of constituents from n butanol fraction 
Eluting solvents          Fractions      
and composition  
(%v/v) 
Compounds             Detection  %yield 
(w/w  of  
crude  
extract) 
CHCl3:MeOH                    01-09 
( 100:0)            
 
        
CHCl3:MeOH                    10-17 
( 95.5)                                                 
 
 
 
 
CHCl3:MeOH                    18-25  
 (90:10)                              26-39   
 
                         
CHCl3:MeOH                    40-57           
(80:20) 
 
CHCl3:MeOH                    58-64   
(50:50) 
 
CHCl3:MeOH                    65-80  
(0:100)  
No residue after 
evaporation 
 
 
Compound I(Rf=0.5)   
 
 
 
 
 
Compound I(Rf =0.5)   
Compound II &III(Rf 
=0.6) 
 
 Compound IV (Very 
less quantity was 
isolated.)  
No residue after 
evaporation 
 
No residue after 
evaporation 
 
 
 
 
 
 
 
On TLC plates 
using 
chloroform: 
methanol 
(90:10v/v) as 
mobile phase 
& iodine 
vapors as 
detecting 
agent 
 
     -- 
 
 
 
     12 
 
 
 
 
 
      5 
     22 
 
 
       -- 
 
 
 
      -- 
 
 
      -- 
 
 Table 6: Separation of constituents from ethyl acetate fraction 
Eluting solvents 
and composition 
(%v/v) 
Fractions    Compounds           Detection    %yield 
(w/w  of  
crude  
extract) 
CHCl3 (100) 
 
 
 
 
CHCl3:ethyl acetate 
(50:50)   
 
 
 
Ethyl acetate (100) 
 
 
 
Ethyl acetate 
:methanol (90:10) 
 
 
Ethyl acetate 
:methanol (50:50) 
Ethyl acetate 
:methanol (00:100) 
1-10 No residue after 
evaporation    
 
 
 
11-21    No residue  after      
evaporation    
 
 
 
22-30    Compound V (Very  
less quantity was isolated.)            
 
 
31-49   Compound VI Rf=0.45 
 
 
 
50-63   Compound VI Rf=0.45 
 
64-78  Compound VII Rf=0.5 
 
 
 
 
 
 
 
 
On TLC plates 
using n butanol: 
acetic acid: water 
(4:1:5) using 
anisaldehyde 
sulphuric acid 
reagent and 
heating at 1100C 
for 5 minutes. 
 
 
 
 
 
 
 
     -- 
 
 
 
 
     -- 
 
 
 
 
 
    -- 
 
 
   06% 
 
 
 
   06% 
 
 
   5.5% 
 Total 03 compounds (including a mixture) were isolated from 80 fractions (each 
of 05 ml) from n butanol fraction. Total 03 compounds were isolated from 78 
fractions each of 05 ml from ethyl acetate soluble fraction. 
Different parameters of the isolates (which were obtained in significant 
quantities) like melting point, solubility in various solvents, reaction to UV light 
were also determined and compared with the reported results.  
       
4.11 Characterization of the compound I, VI, VII and mixture of compound II 
and compound III 
Isolates were identified using following methods and compared with the reported 
data: 
UV spectra of the isolated compounds were recorded in methanol over a 
scanning range of 200-400 nm and λmax of compounds was determined. Spectra 
were recorded with a Shimadzu double beam (UV -1700 E Pharma spec) UV-VIS 
spectrophotometer. IR spectra were obtained using JASCO FT IR 5300 (Japan) 
in KBr disc and absorption peaks in terms of wave numbers (cm-1) were noted for 
each constituent. APCI (atmospheric pressure chemical ionization) mass 
spectrum in positive mode, were recorded on Shimadzu LCMS 2010A (Japan) 
instrument. NMR spectra were acquired on Brucker (200MHz) supercon multi 
nuclei probe spectrophotometer (West Germany) at 300 MHz (1H) and 75 MHz 
(13C). Chemical shifts were recorded as δ value (ppm) using TMS (tetra methyl 
silane) as internal standard. The spectra were observed on CDCl3 and /or 
DMSO.D6. Melting point was determined on electronic melting point apparatus 
and reported as incorrect.  
 
4.12 TLC of the isolates: It was performed to further confirm the identity of the 
isolated compounds using previously reported solvent systems. For this study all 
the compounds were dissolved in methanol and applied on TLC plates. 
   
 Compound I  
Solvent system      Hexane: diethyl ether: acetic acid (78:20:04) 
         Detecting agent                        Liebermann–Burchard reagent; heated for 10    
minutes at 110oc.  
Mixture of compound II and compound III 
Solvent system    Chloroform: toluene (95:05) 
Detecting agent  Liebermann –Burchard reagent; heated for 10 
minutes at 110oc. 
Compound VI 
Solvent system A   BAW (n butanol:  acetic acid: water; 4:1:5) 
Solvent system B   15% acetic acid 
Detecting agent                             Iodine vapors  
Solvent systems C [Ethanol: ammonia (90:10)] was also tried and the plate was 
treated with ammonia and observed under UV light.  
 
Hydrolysis of compound VI: It was done to further separate aglycone and 
glycone of compound VI (as spectral studies revealed it as isoquercitrin). Both 
these were further tested by TLC study as mentioned under:  
 
Acidic hydrolysis of compound VI88: A small amount of the compound was 
hydrolyzed by dissolving it in 1 ml of 2N HCl and then the solution was heated on 
a boiling water bath for 1 hour. The solution was then extracted with ethyl 
acetate. The aqueous layer was then neutralized with NaHCO3 and evaporated 
to dryness. The residue was then tested for the presence of glycone using paper 
chromatography as mentioned in the next section. The ethyl acetate solution was 
evaporated to dryness and the residue was chromatographed on silica gel plates 
to confirm the presence of aglycone as shown by the spectroscopic studies. 
 TLC of glycone  
The hydrolysate after removing aglycone was applied on Whatman no. 1 filter 
paper for the confirmation of glucose as sugar portion of flavonoid. 
Solvent system A    n butanol: ethanol: water (4:1:2.2) 
Solvent system B    n butanol: benzene: pyridine: water (5:1:3:3) 
           Detecting agent and treatment:   Aniline phthalate reagent (Heated at 1100c for 
10 minutes. 
(Preparation of aniline phthalate reagent89: About 0.93 gm of aniline and 1.66 gm 
of o-phthalic acid were dissolved in 100 ml of n butanol saturated with water.   
 
TLC study of aglycone  
Solvent system A                          Forestal (Con. HCl: acetic acid: water; 3:30:10) 
Solvent system B    BAW (n butanol: acetic acid: water; 4:1:5) 
           Detecting agent and treatment:  Ammonia fumes treated slide was exposed to 
UV radiation.  
 
4.13 Immunomodulatory activity of isolates 
4.13.1 Experiment Animals 
Randomly bred Wistar albino rats (180-200gm) of either sex were used for the 
study of immunomodulatory activity. Animals were housed under standard 
conditions of temperature and 12 hours light/dark cycle and fed with standard 
pellet diet (Pranav agro sales, Ahmedabad) and water ad libitum. All procedures 
were carried out under strict compliance with ethical principles and guidelines of 
the Institutional Animal Ethical Committee constituted as per the direction of the 
Committee for the Purpose of Control and Supervision of Experimental Animals, 
Madras. For in vivo phagocytosis Swiss albino mice (20-25gm), of either sex 
were used. Total three groups of animals were formed; one for control 
(administered only 1% SCMC) and other two separate groups were of isolates 
(oleanolic acid and isoquercitrin). Isolates were tested at a dose of 50 mg/kg 
body weight (after suspending in 1% SCMC in distilled water). Isolates were fed 
 orally with the help of gastric canula. Most optimum dose was selected based on 
the previously published data of the same compounds.  
 
4.13.2 Antigen 
Antigen was used as mentioned previously in 4.4.4.  
 
4.14 Immunomodulatory protocols  
4.14.1 SRBC–induced humoral antibody (HA) titre 
The method described in 4.5.1 was followed here.  
 
4.14.2 SRBC–induced delayed type hypersensitivity (DTH) reaction 
The method described in 4.8.1 was followed here.  
 
4.14.3 In vivo phagocytosis83  
Animals of the treatment group were given respective isolates daily for five days. 
At the end of five days, after 48 hours, mice were injected via tail vein with 
carbon ink suspension (10 µl /g body weight). Blood samples were drawn (in 
EDTA solution, 5 µl) from the retro orbital vein at 0 and 15 minutes; a 25 µl 
sample was mixed with 0.1% sodium carbonate solution (2 ml) and its optical 
density was measured at 680 nm. The phagocytic index (K) was calculated using 
the equation: K= (logOD1-logOD2)/ 15 Where OD1 and OD2   are optical 
densities at 0 and 15 minutes respectively. 
 
4.15 Statistical analysis 
The values are expressed in mean ± SEM. The results were analyzed by using 
one way analysis of variance (ANOVA) followed by Dunnet‟s t test to determine 
the statistical significance.  P< 0.05 was chosen as the level of significance.  
 
  
 
 
 
 
 
Chapter 5 
Results 
 5. Results 
5.1 Extraction 
Dried fruits (500gm) of Lagenaria siceraria were defatted with petroleum ether 
(60-800) and then extracted with methanol to get concentrated petroleum ether 
extract (0.75%w/w) and crude methanol extract (13.5% w/w). After assuring 
preliminary immunomodulatory activity of this methanol extract, another batch of 
dried fruits (2000g) was successively extracted with petroleum ether, 
dichloromethane, chloroform and methanol. Successive methanol extract was 
further fractionated with ethyl acetate and n butanol after suspending in water. 
The yields of different extracts and fractions were as follows: successive 
petroleum ether (1%w/w), dichloromethane (2.64%w/w), chloroform (0.0% w/w), 
methanol extract (15%w/w), ethyl acetate soluble fraction (0.64%w/w), n butanol 
soluble fraction (2.9%w/w) and water soluble residue (9.46). Water soluble 
residue was not studied further. Summary of extraction is given in Table 7.   
 
 Table 7: Different extracts/fractions with their appearance and yield (in gm)  
 
S. No. Extracts/Fractions Color and 
consistency of dried 
extracts/fractions 
Yield(%w/w) 
01 
 
02 
 
03 
Petroleum ether 
 
CME 
 
Successive petroleum 
ether 
Dark green ,oily 
 
Dark brown, sticky 
 
Dark green ,oily 
0.75 
 
13.5 
 
04 Successive  
dichloromethane 
Dark brown, sticky 2.64 
05 Successive chloroform Green ,sticky Nil 
06 n butanol fraction Dark brown, sticky 2.9 
07 
 
08 
Ethyl acetate fraction 
 
Water soluble residue 
Dark brown, gooey 
 
Brown, sticky 
0.64 
 
9.46 
 
 
 5.2 Immunomodulatory activity of CME 
 
5.2.1 Acute toxicity study 
During acute toxicity study, animals were observed for gross behavioral and 
morphological changes (respiratory distress, immobility, convulsion, loss of 
righting reflex etc). During this observation no toxic symptoms were seen. All the 
animals survived the toxicity studies at all dose levels. Based on the study; doses 
were then selected.   
 
5.2.2 Immunomodulatory protocols 
CME significantly increased haemagglutination antibody titre. Primary antibody 
titre was found to be increased in a dose dependent manner. It also increase rate 
of carbon clearance from rats significantly when compared with control group 
animals. CME prevented myelosuppression in rats treated with 
immunosuppressive drug-cyclophosphamide. A significant increase in white 
blood cell count was observed in CME treated rats compared to untreated 
(control) rats. These results are summarized in Tables 8-10 and Figures 6-8.      
 
 Table 8: Effect of CME of Lagenaria siceraria fruits on SRBC-induced 
haemagglutination antibody titre in rats 
 
Values are mean ± SEM, a p>0.05, b p<0.01, c p< 0.05, compared to control group 
animals, (n=6), 10 primary,  20 secondary.  
 
 Fig. 6: Effect of CME of Lagenaria siceraria fruits on SRBC-induced 
haemagglutination antibody titre in rats 
 
Effect of CME of Lagenaria siceraria  fruits on SRBC-
induced haemagglutination antibody titre in rats
0
200
400
Control CME
100
CME
200
CME
500
Animal groups
M
e
a
n
 
a
n
ti
b
o
d
y
 
ti
tr
e
Primary antibody titre
Secondary antibody titre
 
Group Treatment 
(mg/kg) 
       Mean haemagglutination antibody titre 
Range            10 HA titre        Range                     20 HA titre 
Control 
(sensitized) 
- 0-32            32± 0.00             32-64                         37.33±5.33 
CME 100 64-128        117.33±10.66a    64-128                  117.33±10.66b 
CME 
CME 
200 
500 
128-256    149.33±21.33a         64-128                  106.66±13.49c 
128-512    234.66±61.08b     128-256                213.33±26.98b 
 Table 9: Effect of CME of Lagenaria siceraria fruits on in vivo phagocytosis 
in rats 
 
 
 
 
 
 
 
 
Values are mean ± SEM, a p>0.05, b p< 0.01, compared to control group animals, 
(n=6). 
 
Fig. 7: Effect of CME of Lagenaria siceraria fruits on in vivo phagocytosis in 
rats 
Effect of CME of Lagenaria siceraria 
fruits on in vivo  phagocytosis in rats
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(K) 
Control                       - 0.0221±0.000 
CME                        100 0.0228±0.001a 
CME                        200 
CME                        500 
0.0326±0.001b 
0.0438±0.001b 
 Table 10: Effect of CME of Lagenaria siceraria fruits on cyclophosphamide–
induced myelosuppression in rats 
 
 
 
 
 
 
 
 
 
 
Values are mean ± SEM, a p>0.05, b p<0.01, c p< 0.05, compared to 
cyclophosphamide treatment alone, (n=6), CP cyclophosphamide. 
 
 
Fig. 8: Effect of CME of Lagenaria siceraria fruits on cyclophosphamide–
induced myelosuppression in rats 
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Group Treatment 
(mg/kg) 
Total WBC 
(103/mm3) 
Day 0 
Total WBC 
(103/mm3) 
Day 14 
Control - 9.99±0.16 10.4±0.51 
CP 30 9.97±0.19 6.32±1.09 
CME+CP 100 10.15±0.23 6.99±0.34 a 
CME+CP 200 10.11±0.12 8.85±0.38 c 
CME+CP 500 10.15±0.21 10.78±0.28 b 
 5.3 Immunomodulatory activity of successive extracts and fractions of SME 
5.3.1 Acute toxicity study 
During acute toxicity study, animals were observed for gross behavioral and 
morphological changes (respiratory distress, immobility, convulsion, loss of 
righting reflex etc). During this observation no toxic symptoms were seen. All the 
animals survived the toxicity studies at all dose levels. Based on the study; doses 
were then selected.   
 
5.3.2 Immunomodulatory protocols 
Only n butanol and ethyl acetate soluble fractions increased haemagglutination 
antibody titre significantly (p<0.05) in dose dependent manner. Primary as well 
as secondary antibody titres were found to be more at 500 mg/kg in n butanol 
soluble fraction treated animals compared to corresponding values for ethyl 
acetate soluble fraction treated animals. Both these fractions dose dependently 
and significantly (p<0.05) inhibited SRBC-induced DTH reaction as indicated by 
decrease in foot pad thickness of rats compared to control group animals. Both 
these fractions of SME significantly (p<0.05) increased total WBC, neutrophil and 
lymphocyte count while insignificant changes were observed in monocyte, 
eosinophil and basophil counts. These results are summarized in Tables 11-13 
and Figures 9-17.      
   
 Table 11: Effect of successive extracts and fractions of SME on SRBC-
induced haemagglutination antibody titre in rats 
 
Values are mean ± SEM, a p<0.05, ns not significant, compared to control group animals, 
(n=6), 10 primary,  20 secondary 
.  
 
Group Treatment 
(mg/kg) 
Mean hemagglutinating antibody(HA) titre 
Range                10 HA titre                              20 HA titre 
Control 
(sensitized) 
- 32-64                   42.66±6.74                       37.33±5.33 
Petroleum  
Ether 
100 
200 
500 
16-128                 42.66±9.83 ns                    50.66±16.73 ns 
16-64                   40.0±8.0 ns                        45.33±8.68 ns 
16-128                 48.0±17.52 ns                     32.0±0.0ns 
Dicholoro- 
Methane 
100 
200 
500 
32-64                   42.66±6.74 ns                     42.66±6.74ns 
16-128                 40.0±8.0 ns                         48.0±17.52ns 
32-64                   42.66±6.74 ns                     37.33±5.33ns 
n butanol 
 
 
100 
200 
500 
32-256                145.0±39.72 a                    100.25±57.36a 
64-256                192.0±28.62 a                    181.33±34.72a 
256-512              341.33±3.97 a                     298.67±51.97 a 
Ethyl acetate 100 
200 
500 
64-128                117.33±34.65 a                  110.59±23.34a 
64-256                181.33±34.72 a                  100.25±23.34a 
128-256               213.33±26.98 a                 234.66±21.33 a 
 Fig. 9: Effect of successive extracts and fractions of SME on SRBC-induced 
haemagglutination antibody titre (primary) in rats 
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Fig. 10: Effect of successive extracts and fractions of SME on SRBC-
induced haemagglutination antibody titre (secondary) in rats 
 
Effect of successive extracts and fractions of SME on SRBC-
induced haemagglutination antibody titre (secondary) in rats
0
100
200
300
400
Control Petroleum
ether
Dichloro
methane
n butanol Ethyl
acetate
Animal groups
M
e
a
n
 
a
n
t
ib
o
d
y
 
t
it
r
e
100 mg/kg 200 mg/kg 500 mg/kg
 Table 12: Effect of successive extracts and fractions of SME on SRBC-induced delayed type 
hypersensitivity reaction in rats 
 
Values are mean ± SEM, a p<0.05, ns not significant, compared to control group animals, (n=6), 10 primary,  20 secondary.  
Group Treatment 
(mg/kg) 
          Foot pad thickness (mean % edema)                          Inhibition  % (compared to control) 
 
After 24 hour                              After 48 hour               After 24 hour                       After 48 hour 
of  challenge                              of challenge                 of challenge                        of challenge 
Control(sensitized) - 60.56±19.00                                47.5±14.46                            -                                               - 
Petroleum ether 
 
100 
200 
500 
35.24±8.27 ns                                27.87±9.13 ns                        41.80                                      41.32 
64.27±5.79 ns                                56.56±0.38 ns                              6.12                                         19.07                             
77.67±7.08 ns                               66.31±5.42ns                                 28.25                                       39.6 
Dicholoro methane 
 
100 
200 
500 
35.18±14.65ns                             30.36±13.71 ns                      41.90                                       36.08 
23.92±6.47a                                19.17±1.22 a                                    60.50                                       59.64 
35.33±14.50 ns                            24.99±11.79 ns                                41.66                                       47.38 
n butanol 100 
200 
500 
23.19±1.23 a                                15.23±1.24 a                       61.70                                       67.93 
15.16±1.19 a                                10.41±0.32 a                                   74.96                                       78.08 
9.98±0.76 a                                  8.78±0.54 a                                      83.52                                       81.51 
Ethyl acetate 100 
200 
500 
22.18±1.56 a                               14.33±1.52 a                        63.37                                       69.83 
15.14±1.23 a                                11.20±1.94 a                                  75.00                                       76.42 
11.92±0.69 a                                10.17±0.43 a                                  80.31                                       78.58 
 Fig. 11: Effect of successive extracts and fractions of SME on SRBC-
induced delayed type hypersensitivity reaction (after 24 hours of challenge) 
in rats 
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Fig. 12: Effect of successive extracts and fractions of SME on SRBC-
induced delayed type hypersensitivity reaction (after 48 hours of challenge) 
in rats 
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  Table 13: Effect of different fractions of SME on haematological parameters in rats 
Group Treatment 
(mg/kg) 
Total WBC 
(103/mm3) 
Neutrophils 
(%) 
Lymphocyte
s (%) 
Monocytes 
(%) 
Eosinophils       
(%) 
Basophils 
(%) 
Control - 5.88 ± 0.2 30.16 ± 0.7 67.00 ±  2.12 2.00 ± 0.0 1.33 ±0.21 0 ± 0 
n butanol 100 
200 
500 
8.98 ± 0.53a 
10.10 ± 0.46a 
10.91 ± 0.27a 
39.93 ± 0.17a 
40.40 ± 0.70a 
41.16 ± 0.70a 
70.00 ± 1.7ns 
75.00 ± 1.9a 
76.00 ± 1.5a 
2.16 ± 0.20ns 
2.34 ± 0.23ns 
2.66 ± 0.21ns 
2.32 ± 0.43ns 
2.21 ± 0.53ns 
2.16 ± 0.30ns 
0 ± 0ns 
0 ±0ns 
0 ± 0ns 
Ethyl acetate  100 
200 
500 
12.00 ± 0.34a 
12.00 ± 0.97a 
12.79 ± 0.35a 
42.00 ± 0.85a 
43.00 ± 0.12a 
43.33 ± 0.76a 
77.75 ± 2.3a 
79.75 ± 2.8a 
78.00 ± 1.2a 
2.23 ± 0.12ns 
2.30 ± 0.31ns 
2.16 ± 0.30ns  
2.13 ± 0.35ns 
2.14 ± 0.29ns 
2.00 ± .25ns 
0 ± 0ns 
0 ±0ns 
0 ± 0ns 
 Values are mean ± SEM; n=6 in each group; a p<0.05, compared to control; ns=not significant.  
  
Fig. 13: Effect of different fractions of SME on total WBC  
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Fig. 14: Effect of different fractions of SME on neutrophil count  
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Fig. 15: Effect of different fractions of SME on lymphocyte count 
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Fig. 16: Effect of different fractions of SME on monocyte count 
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Fig. 17: Effect of different fractions of SME on eosinophil count  
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5.4 Phytochemical screening of CME and n butanol and ethyl acetate 
soluble fractions of SME 
Pharmacologically active extract and fractions were screened for phytochemical 
study. CME showed the presence of flavonoids, saponins, sterols, tannins and 
carbohydrates. n butanol soluble fraction found to contain sterols, saponins, 
terpenoids and carbohydrates while flavonoids were found in ethyl acetate 
soluble fraction of methanol extract. In TLC study, spots with chromatographic 
behavior identical to flavonoids (green color) and sterols (violet pink color ) were 
observed for ethyl acetate and n butanol fractions respectively. TLC plate for 
ethyl acetate fraction was also sprayed with 1% AlCl3 in methanol and observed 
under UV light. Two yellow spots were observed. Results are mentioned in Table 
14.  
  
Table 14:  Phytoconstituents present in CME and different fractions of SME 
+: Found to be present; -: found to be absent. 
EAF: ethyl acetate fraction; nBF: n butanol fraction. 
Sr. 
No. 
Plant constituents Tests/Reagents CME EAF nBF 
01 Sterols/terpenoids/steroids Salkowaski test  
Liebermann-Burchard 
reagent  
+ 
+ 
- 
- 
+ 
+ 
02 Alkaloids Dragendorff‟s reagent 
Mayer‟s reagent 
Hager‟s reagent 
Wagner‟s reagent 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
03 Tannins Ferric chloride solution 
Lead acetate solution  
+ 
+ 
- 
- 
+ 
+ 
04 Flavonoids Shinoda test 
Lead acetate solution  
+ 
+ 
+ 
+ 
- 
- 
05 Carbohydrates Molisch‟s test 
Fehling‟s reagent  
Benedict reagent   
+ 
+ 
+ 
- 
- 
- 
+ 
+ 
+ 
06 Proteins Biuret test 
Xanthoproteic test 
Millon‟s reagent 
- 
- 
- 
- 
- 
- 
- 
- 
- 
07 Saponins Foam test 
Hemolytic test 
+ 
+ 
- 
- 
+ 
+ 
08 Anthraquinone glycosides Borntrager‟s test - - - 
09 Cardiac glycosides Legal test 
Keller-Kiliani test 
- 
- 
- 
- 
- 
- 
  
5.5 TLC profile of bioactive n butanol and ethyl acetate fractions of SME 
TLC study has shown the presence of different components present in n butanol 
and ethyl acetate fractions when the corresponding fractions were run in specific 
solvent system. Before reaching to most optimum solvent system a number of 
systems were employed as shown in Tables 15-17.     
 
 Table 15: Selection of mobile phase for TLC of n butanol fraction  
 
Sr. 
no. 
Solvent system Observation 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
CHCl3 
CH3OH 
CHCl3:gaa:CH3OH:H2O(64:32:12:8) 
C6H6: CHCl3  (50:50) 
CHCl3:CH3OH (50:40) 
CHCl3:CH3OH (75:25) 
CHCl3:CH3OH (100:50) 
CHCl3:C2H5OH (20:1) 
CHCl3:CH3OH:gaa(50:40:1) 
CHCl3:CH3OH:gaa(50:40:0.5) 
CHCl3:CH3OH:H2O(70:30:4) 
CHCl3:CH3OH (4.5:0.5) 
CHCl3:CH3OH (90:10) 
No change  
Moved along with solvent front 
Poor resolution with tailing  
No movement 
Separated but tailing 
Separated but tailing 
Poor separation 
No separation 
Moved along with solvent front  
Moved along with solvent front  
Separated with slight tailing  
Good separation 
Best separated (Table 17)  
gaa: glacial acetic acid; Triterpene derivatives and saponins were detected by 
the interpretation of the color reaction with vanillin sulphuric acid reagent. 
  
Table16: Selection of mobile phase for TLC of ethyl acetate fraction  
  
Table 17: Summary of TLC  
         
 
Sr. 
no. 
Solvent system Observation 
1 
2 
 
3 
4 
5 
6 
7 
8 
9 
n butanol: acetic acid: water (4:5:1) 
Acetic acid: ethyl acetate: formic acid: water 
(110:100:11:26) 
n butanol: chloroform :methanol ( 1:7:3) 
n butanol: chloroform :methanol ( 1:3:7) 
Toluene: ethyl acetate (85:15) 
Ethyl acetate :methanol: water (100:135:10) 
15% acetic acid 
CHCl3:CH3OH (90:10) 
n butanol: acetic acid: water (4:1:5) 
Poor resolution with tailing 
Separation with tailing 
 
No movement 
Separated but tailing 
No movement 
Poor separation 
Poor separation 
No movement 
Best separated (Table 17)  
Fractions Solvent systems Detecting reagents Color, no, and  Rf of 
spots  
n butanol Chloroform: 
methanol 
(90:10) 
Sprayed with vanillin-
sulphuric acid and heated at 
1000C for 5 minutes. 
Four violet pink spots with 
Rf   values; 0.2, 0.34, 0.38 
and 0.6 were seen. 
Ethyl 
acetate 
n butanol: acetic 
acid: water(4:1:5) 
Sprayed with anisaldehyde 
sulphuric acid and heated at 
1100C for 5 minutes. 
 
Sprayed with 1% AlCl3 in 
methanol and observed 
under UV light 
Five green spots with Rf   
values; 0.44, 0.56, 0.62, 
0.76 and 0.84 were seen. 
 
Two yellow spots were 
spotted at Rf values; 0.44 
and 0.59. 
  
  
5.6 Results of HPTLC of n butanol fraction 
 
  
  
 
  
 
  
  
  
  
5.7 Results of HPTLC of ethyl acetate fraction 
 
  
 
 
  
  
 
  
  
  
5.8 Bioactivity guided isolation and characterization of phytoconstituents 
Flavonoid rich-ethyl acetate and saponin rich-n butanol soluble parts of 
successive methanol extract of Lagenaria siceraria fruits were submitted to silica 
gel column chromatography to yield compounds I, II, III, VI and VII. All the 
compounds were identified by IR, UV, 1H-NMR and 13C-NMR techniques. 
Compound I, II, III, IV and V were identified as oleanolic acid, β sitosterol, 
campesterol, isoquercitrin (quercetin-3 beta-D-glucoside) and kaempferol 
respectively by direct comparison of the spectra with those reported in 
literature90-96.  Different spectroscopic data of the isolates along with spectra are 
given below:  
 
Compound I: Isolated from n butanol soluble part of successive methanol extract 
of Lagenaria siceraria fruits as a white amorphous powder. UVmax :202, 
1H-NMR: 
δ 0.63-1.07(7 CH3),2.73(1H,d,J=13.6 Hz,H-18),3.13(1H,dd,J=9.6  Hz,H-3),5.22 
(1H, J=3.6 Hz, H-12).13C-NMR: δ15.13(C-25), 15.52(C-24), 16.88(C-26), 18.15 
(C-6), 22.84(C-11),23.17(C-30),23.43(C-16) 25.71(C-27),26.97(C-2), 27.52(C15),  
27.98(C-23), 30.50(C-20), 32.29(C-22), 32.53(C-7), 32.94(C-29), 33.73(C-21), 
36.84(C-10),38.27(C-1),38.56(C-4),39.13(C-8),40.94(C-18),41.52(C-14),45.87 
(C-17),46.01(C-19),47.42(C-9),55.05(C-5),78.42(C-3),121.93(C-12),144.5(C-13), 
180.29(C-28). EI-MS m/z (relative intensity):457,439,411,247,203,191,177. IR: 
3468.32, 2945.57, 2862.62, 2652.36, 1697.51 1464.10, 1386.94, 1363.80, 
1323.29, 1304.00, 1273.13, 1238.41, 1209.48, 1184.40, 1091.81, 1032.01, 
997.29, 949.06, 918.20, 885.41, 825.61, 754.23, 679.00, 655.86, 640.42, 603.77, 
565.19.   
 
 
  
HO
H3C CH3
CH3 COOHCH3
CH3
CH3
H3C
I: Oleanolic acid 
 
Following are various spectra of compound I:  
  
 
  
  
  
  
  
  
  
  
  
  
 
  
Mixture of compound II and compound III: Isolated from n butanol soluble part 
of successive methanol extract of Lagenaria siceraria fruits as a white crystalline 
powder. UVmax: 203, 
1H-NMR: δ 5.33(1H,H-6),0.68 (3H,s,Me-18),1.14(3H,s,Me -
19),1.01(3H,d,Me-21),0.82(3H,d,J=6.8 Hz,Me-26),0.80(3H,d,  J=6.4 Hz,Me-27), 
0.84 (3H,t, J=6.6 Hz,Me-29).13C-NMR: δ 11.92 (C-18), 11.97(C-29),18.77(C-
21),18.85(C-27),19.22(C-19),19.51,(C-28),21.16(C-11),23.15(C-28), 24.37 (C-15) 
, 26.2(C-23), 28.31(C-16), 29.26(C-25), 31.69(C-2), 31.98(C-7), 32.05(C-8), 
32.47(C-22),34.03(C-20),36.21(C-10),36.57(C1),37.35(C-14),39.86(C-12),42.38 
(C-13),45.91(C-24),50.22(C-9),56.15(C-17),56.84(C-14),77.42(C-3),121.71(C-
6),140.84(C-5).EI-MSm/z (relative intensity): 414,399,397,395,383,369, 353,303, 
301,275,263,247,219,205,192,181,153,123,101,93,80,69,54.IR:425.89,2935.92,
2868.41,1639.64,1466.03,1379.23,1240.34,1192.12,1134.25,1107.24,1060.94, 
1022.36, 958.71, 839.11, 800.53, 738.80, 626.92. 
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II: β sitosterol        III: Campesterol 
 
Following are various spectra of mixture of compound II and compound III:  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
 
UV spectrum of mixture of compounds II and III 
  
 
 
 
UV spectrum of compounds I 
Fig. 21 : UV spectra of different compounds 
  
Compound VI: Isolated from ethyl acetate soluble part of successive methanol 
extract of Lagenaria siceraria fruits as light green powder. UVmax: 202, 255, 
1H-
NMR:δ3.39-5.33(7H,m,7H of sugar),5.11(1H,d,J=7.3 Hz,H-1”),6.30(1H,s,H-
6),6.30(1H,s,H-8),6.83(1H,d,J=9.0Hz,H-5‟),7.73(1H,s,J=2.1Hz,H-2‟),7.77 (1H, dd 
,J=2.1Hz,9.0  Hz,H-6‟),12.29(1H,s,OH-5‟).13C-NMR: δ 60.14(C-6”),68.56 (C-
4”),72.91(C-2”),75.48(C-3”),76.77(C-5”),92.57(C-8),97.82(C-6),102.07(C-1”),   
103.05(C-10),114.05(C-5‟),115.65(C-2‟),120.08(C-1‟),120.29(C-6‟),132.93(C- 3), 
143.29(C-3‟),147.28(C-4‟),155.45(C-9),156.10(C-2),160.23(C-5),163.22(C-7), 
176.51 (C-4). EI-MS m/z (relative intensity): 465, 303.IR:3260.00, 1660.86, 
1606.85, 1504.61, 1454.46, 1359.94, 1304.00, 1197.90, 1060.94, 1010.79, 
933.63, 798.60, 709.87, 644.28, 592.20. 
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Following are various spectra of compound VI:  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
 
 
Fig. 22 : UV spectrum of compounds VI 
 
  
  
Compound VII: Isolated from ethyl acetate soluble part of successive methanol 
extract of Lagenaria siceraria fruits as light yellow amorphous powder.1H-NMR:δ 
6.12 (1H,d, J=2.3 Hz,H-6),6.32(1H,d, J=2.3 Hz,H-8),6.86 (2H,d, J=8.6 Hz,H-3‟ 
and H-5‟),7.97 (2H,d, J=8.6 Hz,H-2‟ and H-6‟).13C-NMR: δ93.20(C-8),98.07 (C-
6),102.95(C-10),115.11(C-3‟andC-5‟),121.67(C-1‟),129.13(C-2‟andC-6‟), 135.49 
(C-3), 146.27(C-2), 156.12(C-9), 158.89(C-4‟), 160.65(C-5), 163.67(C-7), 
175.54(C-4). EI-MS m/z (relative intensity):287, 288, 319, IR: 3317.86, 
1662.79,1612.64,1568.27,1506.54,1440.96,1383.09,1302.07,1251.91,1224.91,1
176.68,1087.95,1008.86,974.14,883.48,846.83,817.89,794.74, 723.37, 680.93, 
621.13, 584.48, 495.75,408.95. UVmax could not be determined because of 
insufficient quantity. 
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VII: Kaempferol 
 
Following are various spectra of compound VII:  
  
  
  
  
  
  
  
 
  
 
5.9 Determination of various parameters of isolated phytoconstituents 
 
Color and state  
Compound I                        White amorphous powder  
Mixture of compounds II and III   White crystalline powder  
Compound VI                          Light green powder  
Compound VII     Light yellow  
 
Melting point  
Compound I       299-3000 C  
Mixture of compounds II and III    136-1400 C  
Compound VI      225-2290 C 
Compound VII 276-2820 C  
 
Reaction to UV light  
Compound I   No fluorescence when exposed to UV light  
Mixture of compounds II and III  No fluorescence when exposed to UV light  
Compound VI    Yellowish color  
Compound VII   Yellowish green color 
 
Solubility  
Compound I  Soluble in chloroform, methanol, insoluble in water  
Mixture of compounds  
II and III  Soluble in chloroform, methanol, insoluble in water  
Compound VI  Soluble in methanol, ethyl acetate, hot water  
Compound VII Soluble in methanol, ethyl acetate, slightly soluble in 
water  
5.10 TLC of the isolates 
Following are the results of TLC study of the isolates which were found in 
agreement with previously reported data86,93,97-100. Hydrolysis product of 
  
compound VI shown the presence of quercetin (aglycone part of isoquercitrin) 
and glucose (glycone part of isoquercitrin) when it was submitted to TLC study.  
 
Compound I (Oleanolic acid) 
No of spot, Rf   and color      01; 0.77, light violet 
 
Mixture of compounds II and III (Mixture of β sitosterol and campesterol) 
No of spot Rf and color      01; 0.29, dark brown 
(Spot for campesterol could not be seen being very similar to β sitosterol but the 
Rf values were exactly as that of previously published data of β sitosterol). 
 
Compound VI (Isoquercitrin) 
No of spot Rf and color (Solvent system A)  01; 0.61, brown 
No of spot Rf and color (Solvent system B)  01; 0.36, brown 
No of spot Rf and color (Solvent system C) 01; 0.45, yellow, dull 
brown (after treatment with 
ammonia) 
Glycone of compound VI (Glucose) 
No of spot, color and Rf (Solvent system A)  01; 0.17, brown 
No of spot, color and Rf (Solvent system B)   01; 0.25, brown 
 
Alycone of compound VI (Quercetin) 
No of spot and Rf (Solvent system A)   01; 0.4 
No of spot and Rf (Solvent system B)   01; 0.64 
Single spot of yellow color, corresponding to quercetin was observed when 
ammonia fumes treated slide was exposed to UV radiation. Without ammonia 
also spot was seen as yellow in UV. But in day light and in iodine vapors nothing 
was visible. These results are in agreement with the previously published data of 
TLC of aforesaid phytoconstituents.  
  
  
 
Compound I, mixture of compounds II and III, VI and VII were identified as 
oleanolic acid, mixture of β sitosterol and campesterol, isoquercitrin and 
kaempferol respectively by comparison of their spectroscopic, chromatographic 
and other data with the reported values in the literature. 
 
5.11 Immunomodulatory activity of oleanolic acid and isoquercitrin 
 
5.12 Immunomodulatory protocols  
Oleanolic acid as well as isoquercitrin, significantly increased haemagglutination 
antibody titres in rats. Both the isolates significantly (p<0.01) inhibited SRBC-
induced DTH reaction. They also increased carbon clearance from the blood of 
mice significantly (p<0.01) indicating increased phagocytosis. These results are 
summarized in Tables 18-20 and Figures 24-26.      
 
Table 18: Effect of oleanolic acid and isoquercitrin on SRBC-induced 
haemagglutination antibody titre in rats 
Values are mean ± SEM, a p< 0.05, b p>0.05, c p < 0.01, compared to control 
group animals,(n=6),10 primary,  20 secondary 
 
 
Group Treatment 
(mg/kg) 
Mean haemagglutination antibody(HA) titre 
Range            10 HA titre                       20 HA titre 
Control(sensitized) - 32-64           37.33±5.33                 32.0 ±0.0 
Oleanolic acid 
Isoquercitrin 
50 
50 
64-128       234.66±61.08 a           106.66 ±31.64b 
128-512      213.33±63.28a             149.33±21.33 c 
  
Fig. 24: Effect of oleanolic acid and isoquercitrin on SRBC-induced 
haemagglutination antibody titre in rats 
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Table 19: Effect of oleanolic acid and isoquercitrin on SRBC-induced delayed type hypersensitivity 
reaction in rats 
 
Values are mean ± SEM, c P < 0.01, compared to control group animals, (n=6) 
Group Treatment 
(mg/kg) 
Foot pad thickness (mean % edema)                          Inhibition  % (compared to control) 
 
After 24 hour                              After 48 hour                After 24 hour                       After 48 hour 
of  challenge                              of challenge                  of challenge                        of challenge 
Control(sensitized) - 61.66±1.28                                44.3±0.65                                   -                                         - 
Oleanolic acid 
Isoquercitrin 
50 
50 
29.15±0.5 c                                23.97±0.65 c                                  52.72                                  45.89 
24.31±1.06 c                             22.44±0.97 c                                  60.57                                  49.34 
  
Fig. 25: Effect of oleanolic acid and isoquercitrin on SRBC-induced delayed 
type hypersensitivity reaction in rats 
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Table 20: Effect of oleanolic acid and isoquercitrin on in vivo phagocytosis  
 
 
 
 
 
 
 
Values are mean ±SEM, c p<0.01, compared to control group animals, (n=6) 
 
 
Group                  Treatment 
                              (mg/kg) 
Phagocytic index 
(K) 
Control                     - 0.0225±0.000 
Oleanolic acid        50 0.0336±0.001 c 
Isoquercitrin           50 0.0385±0.002 c 
  
  
Fig. 26: Effect of oleanolic acid and isoquercitrin on in vivo phagocytosis in 
mice 
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Chapter 6 
Discussion 
  
6. Discussion   
Many clinical disorders are associated with the immune system. Suppression of 
the immune system is required in the management and treatment of inflammation 
and allergic diseases, while stimulation is highly desirable for the treatment of 
HIV, immunodeficiency and infectious diseases101. Modulation of immune 
response through stimulation or suppression may help in maintaining a disease 
free state. Apart from being specifically stimulatory or suppressive; certain agents 
have been shown to possess activity to normalize or modulate 
pathophysiological processes and are hence called immunomodulatory agents24.  
 Natural products are the most consistent and successful source of drugs. 
Plants remain one of the main sources of natural products for new therapies. 
Two hundred years ago, Horace Walpole read a poem about three princes from 
the land of Serendip (now Sri Lanka) who made discovery they weren‟t looking 
for, and he invented the word serendipity to mean a lucky discovery. A lot of trial 
and error and a lot of serendipities have gone into finding medicines. Sometimes 
by a lucky accident a healer hit upon the right part of the right plant, the right 
dose at the right time-like willow bark to relieve pain. And when he or she did, the 
recipe became part of that healer‟s materia medica, or list of ingredients for 
medicine102.  
Constant increase in antibiotic resistant strains of microorganisms has 
prompted scientists to look for herbal immunomodulators to treat various 
infections4. Many researchers had suggested that most of the therapeutic effects 
of plant extracts are mainly due to their influence on immune system. Modulation 
of immune functions using medicinal plants and their products as a possible 
therapeutic measure has become fundamental principle of therapeutic approach.  
There is growing interest in identifying and characterizing natural 
compounds with immunomodulatory activity ever since their possible use in 
modern medicine has been suggested. They include compounds such as 
polysaccharides, phenolic compounds, alkaloids etc. India has many number of 
plant species and medicinal properties have been assigned to several 
thousands. Indian medicinal plants are rich source of substances that are 
  
claimed to induce paramunity (the non specific immunomodulation). Being non 
specific it is expected to give protection against different pathogens including 
bacteria, fungi, viruses etc. and constitute an alternative or adjunct to 
conventional chemotherapy103. 
Though a number of medicinal plants are available and traditionally used 
to treat variety of disease conditions but much of them remain to be explored 
scientifically for their immunomodulatory effects. Since natural products, 
especially Indian medicinal plants, are the potential source of immunomodulatory 
compounds10, the present study was performed to evaluate Lagenaria siceraria 
(cucurbitaceae) fruits for their possible immunomodulatory activity in 
experimental animals.   
Lagenaria siceraria (Molina) Standley (family cucurbitaceae), commonly 
known as lauki (Hindi) and bottle gourd (English), is a medicinal plant and 
utilizable species. The plant enjoys the reputation of being one of the earliest 
plants to be domesticated on the earth. It is a climbing or trailing herb with bottle, 
oval or dumbbell shaped fruit. Lagenaria siceraria fruit is traditionally used for its 
various biological activities. Phytochemical profile of the plant has shown the 
presence of terpenoids, phenolic compounds besides carbohydrates and tannins 
but so far there has not been any reporting of immunomodulatory activity 
ascribed to these metabolites of the fruits of Lagenaria siceraria.  It was therefore 
concluded that there is paucity of data available on the effect of Lagenaria 
siceraria fruits on immune system, so the current study was undertaken to 
investigate the immunomodulatory effect of different extracts/fractions of 
Lagenaria siceraria fruits in experimental animals using a gamut of protocols. 
Bioactivity guided fractionation led to separation of oleanolic acid, a mixture of β 
sitosterol and campesterol from n butanol soluble fraction and isoquercitrin and 
kaempferol from ethyl acetate soluble fraction of successive methanol extract of 
Lagenaria siceraria fruits. Two of the isolates, oleanolic acid and isoquercitrin 
were tested in experimental animals for their effect on immune system.  
In present study dried fruits of Lagenaria siceraria were extracted with 
methanol using soxhlet apparatus. CME was then evaluated for its possible 
  
immunomodulatory activity in rats using such parameters as haemagglutination 
antibody titre, carbon clearance rate and cyclophosphamide-induced 
myelosuppression. Methanol extract of Lagenaria siceraria fruits significantly 
increased haemagglutination antibody titre. Primary antibody titre was found to 
be increased in dose dependent manner. The extract also increased rate of 
carbon clearance from rats significantly, indicating increased in vivo 
phagocytosis. Extract prevented myelosuppression in rats treated with 
immunosuppressive drug-cyclophosphamide. A significant increase in white 
blood cell count was observed in methanol extract treated rats as compared to 
untreated (control) rats. The results obtained in the present study showed that 
the CME displays dose dependent immunomodulatory effects. 
After confirming the preliminary immunomodulatory activity, another batch 
of dried powder was successively extracted with petroleum ether (60-800), 
dichloromethane, chloroform and methanol. SME was then suspended in water 
and fractionated with ethyl acetate and then n butanol in a separatory funnel to 
enrich crude methanol extract into flavonoids and saponins respectively. 
Petroleum ether extract, dichloromethane extract, ethyl acetate soluble fraction 
and n butanol soluble fraction were then investigated for their immunomodulatory 
activity in rats using such parameters as haemagglutination antibody titre, 
delayed type hypersensitivity reaction and hematological parameters. Only ethyl 
acetate and n butanol soluble parts of SME found to be effective. They showed 
promising immunomodulatory activity. 
Bioactive fractions were then tested chemically to know the presence of 
different chemical constituents. TLC and HPTLC studies were also performed to 
know the number of constituents present in both the fractions and to establish 
finger print profile for the varied fractions of bioactive SME. Flavonoids, saponins, 
tannins and carbohydrates have been reported to be present in fruits of 
Lagenaria siceraria by earlier researchers. They are also the rich source of 
vitamin C. In present investigation, phytochemical screening showed the 
presence of sterols, terpenoids, saponins, carbohydrates (n-butanol soluble 
fraction) and tannins, flavonoids, carbohydrates  (ethyl acetate soluble fraction), 
  
while the crude methanol extract was found to contain flavonoids, saponins, 
sterols, carbohydrates and tannins. TLC findings were in agreement with the data 
of qualitative chemical tests and the spots characteristic for flavonoids and 
saponins were observed.  
Column chromatography was performed to separate phytoconstituents 
from bioactive n butanol and ethyl acetate fractions by applying variety of mobile 
phases. Total five compounds were isolated in significant amount and their 
characterization was done using different spectral techniques (1H-NMR,13C-
NMR, IR and UV analyses) based on the following deliberations, to reveal their 
identity as oleanolic acid (I), β sitosterol (II), campesterol (III), isoquercitrin (VI) 
and kaempferol (VII):  
 
Compound I 
Compound I was obtained as a white amorphous solid which gave positive 
Lieberman-Burchard test for triterpenes. The presence of Δ12–oleane skeleton 
was confirmed in the 13C-NMR spectrum with the signals in the region δ 15.13-34 
ppm, at δ121.93 and at δ144.56 attributed respectively to seven methyl groups, 
to C-12, C-13 and Δ12–oleane skeleton. The assignments of various carbon 
atoms in 13C-NMR spectrum were made through comparison with published 
spectrum of oleanolic acid. The presence of this skeleton was also supported by 
the mass spectrum of the compound, which showed prominent fragments ion 
peak characteristic of cleavage of B and C rings at m/z 247 and 203. The ion 
fragment at m/z 203 indicated the presence of a carboxylic group in the ring D.  
The base peak appeared at m/z 439 characteristic for pentacyclic 
triterpene of β amyrin series with a 12-13 double bond. It showed peak at m/z 
457, in agreement with the molecular formula C30H48O3. IR spectrum of the 
compound showed characteristic bands at 3482.32(OH), 1697.51(olefinic 
C=C).The UV spectrum showed absorption band at λmax 202 nm. 
1H-NMR 
spectrum showed the presence of an olefinic proton resonating at δ 5.22(1H) 
(typical of Δ12–oleane skeleton and a carbinylic proton at δ3.13 (1H) which were 
assigned to H-12 and H-3α respectively. The same spectrum also showed singlet 
  
for seven methyls in the region δ 0.0630-1.0740. Based on above data and by 
comparing its spectroscopic data with those reported in literature, compound was 
I deduced as (C30H48O3, 456.71). 
 
Compound II and III 
Mass spectrum of the mixture was characterized by protonated molecular ions 
(m/z 397) and an abundant signal corresponding to fragment ion due to the loss 
of a water molecule. A signal at m/z 383 was attributed to the [M+Z-H2O]
+ ion of 
campesterol. Intense fragment ion m/z 397 was observed for β sitosterol 
indicating the loss of water [M+Z-H2O]
 +. It seems to be characteristic for sterols 
as dehydration was observed in earlier reports with phytosterols. Peaks at m/z 
400,383,367,275 and 263 were found to be identical to the corresponding mass 
spectrum of campesterol. The IR spectrum showed the presence of a hydroxyl 
group (3425.89 cm-1) and C=C (1639 cm-1) indicating unsaturation in the 
molecule. A band at 2935.92 cm-1 shows the presence of angular methyl group. 
The UV maximum was observed at 203nm.Mixture gave positive Liebermann-
Burchard test. In the 1H-NMR spectrum of the mixture, a one–proton signal 
appeared at δ 5.33 which indicated the presence of an olefinic proton at C-6 
owing to the double bond between C-5 and C-6. Singlets at δ 0.68 and 1.14 for 
the angular methyl groups C-18 and C-19 and doublets at δ 1.01, 0.82, 0.80 and 
a triplet at 0.84 confirm the presence of C-21, C-26, C-27, and C-29 methyl 
groups respectively.13C- NMR showed signals corresponding to sterol nucleus. 
On the above deliberations, isolate was deduced as mixture of β sitosterol and 
campesterol. 
 
Compound VI 
13C-NMR spectrum of the compound showed signals which suggested the 
presence of a flavonoid moiety and a sugar moiety. The sugar moiety was 
determined as β glucose from the analysis of 1H and 13C-NMR spectroscopic 
data. The β–anomeric configuration of compound VI was derived from coupling 
constant (J=6.9) for glucoside. In mass spectrum, the signal at m/z 465 
  
corresponded to the [M+H] + psedomolecular ion, while [A+H]+ at m/z 303 (which 
is a protonated molecule of quercetin), the most important peak was attributed to 
the quercetin aglycone [464-162+H]. Compound was unambiguously identified as 
isoquercitrin (C21H20O12) based on its intense molecular ion [M+H] 
+ peak at 465. 
IR spectrum showed a strong absorption band at 1660.86 cm-1 for a carbonyl and 
an intense broad band at 3260.00cm-1. UV spectrum showed absorption bands 
at 202 and 255 nm, typical of 3–substituted flavonols. The aromatic region of the 
1H-NMR spectrum of the compound has the characteristic set of signals of 
quercetin moiety.1H-NMR signals at δ 6.14 (1H, s), 6.30(1H, s) are due to 
metacoupled protons of A ring (H-6 and H-8) of a flavonoid nucleus (5,7 
dihydroxy flavonol). Signals at δ 6.83, d, J=9Hz; 7.73, d, J=2.1Hz and 7.77, d 
J=9Hz are assigned to H-5‟, H-2‟ and H-6‟ of the ring B respectively. This 
indicates 3‟, 4‟ dihydroxy structure corresponding to aromatic ring B of quercetin 
nucleus. A doublet at 5.11 ppm due to proton of anomeric carbon (C-1”) of the 
sugar moiety indicated unequivocally the configuration for the sugar (glucose) of 
isoquercitrin. 1H and 13C-NMR spectra of compound VI revealed the archetypal 
signals of flavonol glycosides.  The 1H-NMR and 13C-NMR data of this compound 
were consistent with reported data of isoquercitrin. On the above deliberations, 
compound VI was deduced as isoquercitrin. 
Compound VII 
The 1H-NMR spectrum of compound VII displayed the characteristic signals of 
the kaempferol nucleus: two doublets at δ 6.12 and 6.32 ppm (J =2.3Hz), 
assigned to the H-6 and H-8 protons respectively and a pair of A2B2 aromatic 
system protons at δ 6.86 and 7.97 ppm (J =8.6 Hz), assigned to H-3‟ and 5‟ and 
H-2‟,6‟ respectively. A 100% base peak [M]+ for compound was observed at m/z 
287 in the mass spectrum indicating the compound as kaempferol. IR spectrum 
showed a strong absorption band at 1662.79 cm-1 and an intense broad band at 
3317.86cm-1. 13C-NMR signals were found to be in agreement with reported 
values. The molecular formula was deduced from 1H, 13C-NMR and mass 
spectrometry. On the basis of spectral evidences, the structure of compound VII 
was decided to be kaempferol (C15H10O6, 286.2). 
  
In this work we are reporting for the first time the isolation of oleanolic 
acid, isoquercitrin and kaempferol from the fruits of Lagenaria siceraria. 
Previously stigmasterol, campesterol have been isolated from the fruits of 
Lagenaria siceraria. Kaempferol and quercetin 3-O-rutinoside were found in 
pollen of Lagenaria siceraria. Previously from the herb Lagenaria siceraria; 
isovitexin, isoorientin, saponarin 4-O-glucoside have been reported.   
A high degree of cell proliferation renders the bone marrow a sensitive 
target particularly to cytotoxic drugs. In fact, bone is the organ most affected 
during any immunosuppression therapy with this class of drugs. Loss of stem 
cells and inability of the bone marrow to regenerate new blood cells results in 
thrombocytopenia and leucopenia24. Cyclophosphamide has particularly an 
intense effect on short-lived lymphocytes, known to include a great proportion of 
B cells and is also one of the most potent inhibitors of antibody production in 
most species104. Thus cyclophosphamide-induced myelosuppressed animal 
model is a reliable, convenient and reproducible experimental system. In present 
investigation, administration of CME increased total WBC count significantly, 
which was lowered by cyclophosphamide. The results of the present study 
indicate that the test drug can stimulate the bone marrow activity and 
haemopoetic system105. CME offered protection against immunosuppression 
caused by cyclophosphamide and therefore it may be supplemented in cancer 
therapy to deal with adverse effects of cyclophosphamide, though the detailed 
investigations are must. In other similar studies many natural extracts exhibited 
immunostimulatory activity in immunocompromised animals25,45.    
Humoral and DTH reaction to SRBC, administered to rat without adjuvant, 
provide a useful system for identification of compounds with selective effect on 
the immune response. However precise timing of drug administration in relation 
to sensitization and challenge is required25. Injecting rats with 108 SRBCs 
suspended in saline sensitizes them for elicitation of DTH reaction and also 
induces antibody synthesis, therefore this system has major advantages i. e. it 
enables two arms of immune system to be measured in the same species under 
ideal condition and is relatively simpler to perform2.   
  
The humoral immunity involves interaction of B cells with the antigen and 
their subsequent proliferation and differentiation into antibody secreting plasma 
cells. Antibody functions as the effector of the humoral response by binding to 
antigen and neutralizing it or facilitating its elimination by cross-linking to form 
clusters that are more readily ingested by phagocyte cells106. Lagenaria siceraria 
fruits seem to stimulate lymphocyte proliferation which in turn leads to production 
of cytokines that activate other immune cells such as B cells, antigen-presenting 
cells and other T cells.  Studies such as lymphocyte transformation and cytokine 
studies are required for the exact mechanism107.  
Antibody molecules, a product of B lymphocytes and plasma cells, are 
central to humoral immune response; IgG and IgM are the major 
immunoglobulins which are involved in the complement activation, opsonization, 
neutralization of toxin etc23. The antibody production of T dependent antigen, 
SRBCs, requires the co-operation of T and B–lymphocytes and macrophages. 
The augmentation of humoral response by CME, fractions of SME and isolates 
as evidenced by an enhancement of antibody responsiveness to SRBC in rats as 
a consequence of both pre and post immunization sample treatment, indicates 
the enhanced responsiveness of macrophages and B lymphocyte subsets 
involved in antibody synthesis108. Both the fractions significantly inhibited SRBC-
induced DTH reaction as indicated by decrease in foot pad thickness of rats 
compared to control group. Both the fractions, significantly increased 
haemagglutination antibody titre in dose dependent fashion. Primary as well as 
secondary antibody titres were found to be more at 500 mg/kg in n-butanol 
soluble fraction treated animals compared to corresponding values for ethyl 
acetate soluble fraction treated animals.  
DTH reaction is a part of the process of graft rejection, tumor immunity 
and many intracellular infectious, especially those causing chronic diseases such 
as tuberculosis. DTH reaction requires the specific recognition of a given antigen 
by activated T lymphocytes, which subsequently proliferate and release 
cytokines. These in turn increase vascular permeability, induce vasodilatation, 
  
macrophage accumulation and activation, promoting increased phagocytic 
activity and increased concentrations of lytic enzymes for more effective killing106.     
Certain plant originated compounds have the capacity to inhibit 
hypersensitivity reaction105. Our fractions and isolates also inhibited DTH reaction 
significantly. DTH reaction is antigen specific and causes erythema and induction 
at the site of antigen injection in immunized animals. The histology of DTH 
reaction can be different for different species, but the general characteristics are 
an influx of immune cells at the site of injection, and induction becomes apparent 
within 24-72 hours. T-cells are required to initiate the reaction24. The interaction 
of sensitized T-cell with presented antigen is known to be associated with the 
release of mediators such as histamine, products of arachidonic acid metabolism 
(prostaglandin or leukotrienes) and eventually interferon γ leading to DTH 
reaction109. TH1 response stimulates the cytokine profile which activates mainly 
TH cells and macrophages whereas TH2 response activates mainly B cells. 
Immune response involved here is TH1 response since delayed type 
hypersensitivity reactions are mediated by specific T cells together with dendritic 
cells, macrophages and cytokines especially interleukin 1. The overall effect of 
these cytokines is to draw macrophages into the area and activate them, 
promoting increased phagocytic activity and increased concentration of lytic 
enzymes for more effective killings. As enzymes leak out of the activated 
macrophages into surrounding tissues, localized tissue destructions can be 
ensured. These non specific destructions of cells in chronic DTH reaction, 
characterized by excessive number of macrophages, continual release of lytic 
enzymes, are not desirable110.  
Decrease in the hypersensitivity reaction to SRBC in experimental animals 
indicates the inhibitory effect of fruits on chemotaxis dependent leukocyte 
migration. In the early hypersensitivity reaction, antigen-antibody–formed 
immune complexes (IC) are known to induce local inflammation with increase 
vascular permeability, edema and infiltration of polymorphonuclear leukocytes 
(PMNL). The early increase in vascular permeability as well as neutrophil influx 
has been ascribed to the complement C5a fragment which is activated by the IC. 
  
Several low molecular mass compounds responsible for inhibition of production 
of free oxygen radicals from activated PMNL have been identified in Picrorriza 
kurroa111. Lagenaria siceraria fruits produced a decrease in DTH reaction in rats 
showing suppression on T lymphocytes and accessory cell types required for the 
expression of the reaction112.               
Therefore the inhibitory action of n-butanol and ethyl acetate fractions and 
isolates could be due to their influence on the biological mediators. It is in 
accordance with the previously published data on anti-inflammatory activity of 
Lagenaria siceraria fruits43. Decreased DTH reaction may further be explained by 
simultaneous presence of high titres of antibodies, promoting the elimination of 
antigen by non–presenting phagocytes109. The exertion of an immune response 
needs a certain threshold dose, beyond which it does not show enhancement 
and it has also been reported that immunostimulating substance could exhibit 
suppressive effects83. Extracts of a diverse range of plants have been shown to 
possess immunomodulatory properties by presenting simultaneous 
immunostimulatory and immunosuppressive effects113-114. The above 
phenomenon was observed in the case on HA titre and DTH reaction. Many plant 
products used in traditional medicine have been reported to have 
immunomodulating activities. While some of these stimulate both humoral and 
cell mediated immunity (CMI), others activate only cellular components of the 
immune system, i. e. phagocytic function without altering the humoral or CMI. 
Some suppress both humoral and CMI15.  
Phagocytosis is the process by which certain body cells, collectively                                                                
known as phagocytes, ingest and removes microorganisms, effete or malignant 
cells, inorganic particles and tissue debris23. Phagocytosis by neutrophil 
constitutes an essential arm of the host to defend against foreign antigen. 
Neutrophils have receptors for fragment crystallizable (Fc) and complement 
component (C3b) which are involved in the uptake of foreign antigen
12. The role 
of phagocytosis is primarily the removal of microorganism and foreign bodies and 
also the elimination of dead or injured cells. Phagocytosis by macrophages is 
important against microorganism and its effectiveness is markedly enhanced by 
  
opsonization of parasite with antibody and complement C3b leading to more 
rapid clearance of parasite from blood. The mononuclear phagocytic system is 
composed of the bone marrow monocyte precursor, circulating monocyte and 
macrophages in all tissues including lung, liver, spleen, adrenal glands, intestine 
and bone marrow.  These cells are highly phagocytic and participate in the 
eradication of invading microorganisms and clearance of damaged tissues. 
Phagocytic defects are associated with varied pathological conditions in humans. 
Carbon clearance test is the simplest model to test phagocytosis. It is the 
test of phagocytosis efficiency and can be correlated with in vitro granulocyte 
test31. When the carbon particles are injected intravenously, the rate of clearance 
of carbon from blood by macrophage is governed by an exponential equation 
.This seems to be the general way in which inert particulate matter is cleared 
from the blood. The clearance rate of granular foreign bodies from the circulation 
reflects the phagocytic function of mononuclear macrophages.  
In view of pivotal role played by the macrophages in coordinating the 
processing and presentation of antigen to B cells, CME and isolates were 
evaluated for their effect on macrophage phagocytic activity106. For this the index 
of blood clearance was measured with Indian ink as the granular foreign body. 
Administration of CME and isolates enhanced the carbon clearance rate from 
circulation in rats significantly compared to animals of control groups.  
The majority of all the cells type involved in the immune system are 
produced from common haemopoetic stem cells of bone marrow. Bone marrow 
also provides microenvironment for antigen dependent differentiation of B-cells. 
Since both the fractions increased circulating antibody titre, it was thought 
worthwhile to evaluate their effect on peripheral blood counts. Both the fractions 
significantly increased total WBC, neutrophil and lymphocyte counts, while 
insignificant changes were observed in monocyte, eosinophil and basophil 
counts. The increase in percentage of neutrophil in the blood upon treatment with 
both the fractions may be interesting. This may help in increasing the general 
resistance of the body, as polymorphonuclear cells (PMNs) are the primary cells 
which engulf and eliminate invading microorganism, against microbial 
  
infections103. This finding indicates fractions‟ effect on haematopoiesis. Both 
innate and adaptive immunity depends upon the activities of WBC. The innate 
and adaptive immune system together provides a remarkably effective defense 
system6.  
Saponins and flavonoids have long been recognized to possess a wide 
variety of biological activities including immunomodulatory property which could 
explain the results of immunological analysis of Lagenaria siceraria115-120. Many 
researchers have reported possible immunostimulatory activity with steroidal 
saponins121; however possible correlation of immunomodulation and saponins 
content of Lagenaria siceraria fruits was to be established.     
Several studies have shown that therapeutic activity of various extracts of 
higher plants may be mediated by interaction with the host‟s immune system and 
saponins may in part contribute to their medical uses. Several saponin 
glycosides isolated from medicinal plants have been discovered to possess 
significant immunomodulatory effects. Saponins have shown stimulatory effects 
on the components of specific immunity and on monocyte proliferation. Quillaia 
and other saponins either as crude mixture or as purified compounds have been 
reported to increase immune cell proliferation in vitro and boost antibody 
production. Ginseng and astragalus are other plants having saponins as their 
major constituents with proved immunomodulatory activity. Saponins from other 
plants of cucurbitaceae family have been reported to possess immunomodulatory 
activity122. 
Several triterpenoids, isolated from medicinal plants have been discovered 
to posses significant immunomodulatory effects123,6. Oleanolic acid has shown 
promising immunomodulatory effects in our study. Earlier researchers have 
reported the anti-inflammatory, anti-ulcer, hepatoprotective, antihyperlipidemic 
and anti tumor- promotion effects of oleanolic acid110,124-125.  
Phenolic compounds, including flavonoids, have been previously found to 
stimulate or suppress the immune system due to their OH- groups in the structure 
that can affect the enzyme or electron transferring system. The effect will result in 
an immunomodulatory activity especially on phagocytic activity126. 
  
Flavonoids, known for their antioxidant and anti-inflammatory activities, 
are implicated in the maintenance of the health. They also inhibit LDL (low 
density lipoprotein) oxidation and impart cardioprotective effects, which are the 
reported uses of Lagenaria siceraria fruits127-128.  
 Flavonoids have been reported for various pharmacological properties 
including, anticancer and immunomodulatory effects129. Many more reports are 
there for effect on varied cells of immune system104. Recent reports indicate that 
several types of flavonoids stimulate human peripheral blood leukocyte 
proliferation. They significantly increase the activity of helper T cells, cytokines, 
interleukin 2, interferon γ and macrophages and are thereby useful in the 
treatment of several diseases caused by immune system dysfunction. These 
observations indicate that flavonoids have potential to modulate immune system. 
The flavonoids isolated from Lagenaria siceraria by us, are extensively 
distributed in plant kingdom and all have been reported to have biological 
activities. A known flavonol glycoside-quercetin-3-O-β-D-glucopyranoside had 
been reported to increase in vitro phagocytic index. It also showed a significant 
increase in antibody titre and carbon clearance and delayed type hypersensitivity 
reaction in mice130.    
Isoquercitrin has shown to posses antibacterial activity, antiviral activity 
against HSV–virus and it is also known inhibitor of ACE131. It also suppresses 
release of inflammatory mediators. Our results showed the immunomodulatory 
activity of isoquercitrin, indicating its possible role in aforementioned conditions, 
involving immunological backgrounds. There are several reports of the efficacy of 
quercetin against infection of bacteria, fungi and viruses and its anti-allergy and 
anti-inflammatory effects on immune system132. But this is the first report of 
immunomodulatory activity of glucoside of quercetin (isoquercitrin). 
This is the first report on the presence of isoquercitrin, oleanolic acid and 
kaempferol in the fruits of Lagenaria siceraria. We reported the 
immunomodulatory property of the oleanolic acid and isoquercitrin using different 
animal models. These compounds may account at least in part, for the use of 
  
Lagenaria siceraria fruit in folk medicine to treat various diseases involving 
immunological backgrounds.  
Because of scarcity, kaempferol could not be tested pharmacologically but 
contemporary research revealed that kaempferol isolated from medicinal plants 
have several pharmacological actions like antioxidant, anti-malarial, antiviral etc. 
Kaempferol was also reported to have antibacterial and hepatoprotective 
activities131. Being in mixture form, compound II and III could also not be 
evaluated for their effect on immune system. β sitosterol has been tested for its 
immunomodulatory and anti-inflammatory activities besides many other biological 
activities132. The Brazilian folk medicine, sucupira seed, which has been used for 
attenuation of inflammation, has shown clinical and immunomodulatory effects in 
collagen II-induced arthritis in mice. Suppression of B cell and CD4 T cell 
activation, by sucupira seed extracts, lends evidence for its usage in chronic 
inflammatory diseases. β sitosterol and sitosterolin (β sitosterol glucoside) are 
found in leaf extracts. The combination of the two proves to have profound anti-
inflammatory effects and immunomodulatory actions133.  
Numerous clinical documents evidenced that many pathological conditions 
are closely related to impaired antioxidant capability and lower immunity. Much 
research has been focused on the exploration of efficient antioxidant and/or 
immunostimulators that can be used as adjuvant for preventing or curing 
purposes134. The possibilities of antioxidant activity of natural products due to 
their immunomodulatory activity have been reported by earlier researchers. Most 
of the immunomodulators possess antioxidant potential135. Lagenaria siceraria 
fruits have also been reported to possess antioxidant activity. Oxidant-antioxidant 
balance is an important determinant of immune cell function, not only for 
maintaining integrity and functionality of membrane lipids, cellular proteins and 
nucleic acids, but also for control of signal transduction and gene expression in 
immune cells. Cells of immune system are particularly sensitive to change in 
oxidant-antioxidant balance because of higher percentage of polyunsaturated 
fatty acids in their plasma membranes. These cells are frequently exposed to 
change in this balance because of the higher number of reactive oxygen species 
  
(ROS) produced as part of their normal function136. ROS are frequently 
generated in aerobic bodies and scavenged by antioxidants. Excessive amount 
of ROS will induce oxidative damage to macromolecules and finally impair 
functions of organs. Accumulating evidences strongly suggest that such oxidative 
stress is an important causative factor for aging, brain dysfunction, liver ailments, 
cardiovascular disorders, immunodeficiency and carcinogenesis. Lagenaria 
siceraria fruits are rich source of antioxidant substances like flavonoids, tannins 
and other polyphenolic compounds, which may be responsible for the observed 
immunomodulatory activity. Fruits also contain vitamin B and C. Antioxidant 
supplementation has been proved to preserve an adequate function of immune 
cell against homeostatic disturbances caused by oxidative stress. Protection of 
immune system by dietary antioxidants may play an important role in preserving 
the immune function and achieving healthy ageing134.    
The immune system has connections with a number of organs and can 
directly or indirectly influence the actions of many other organs, including the 
brain. By acting primarily on the immune cells like macrophages,; the simple 
chemical of the herbs, by activating cytokine network, could produce all the 
actions that have been attributed to them137.  
Anti-inflammatory activity of Lagenaria siceraria fruits have been 
evaluated by Ghule et al43 using different parameters such as ethyl 
phenylpropionate-induced ear edema, carrageenin and arachidonic acid-induced 
hind paw edema and also the albumin–induced-paw edema in rats. Our finding of 
DTH reaction was found in agreement with these reported parameters involving 
immunological background. Literature is replete with reports of the plants with 
anti-inflammatory activity and immunomodulatory activity of the same plants138. 
A Ribosome inactivating protein (RIP), lagenin has also been isolated from 
Lagenaria siceraria fruits. Other RIPs from plants of cucurbitaceae family have 
been investigated for their anti AIDS activity in animals139. All these reported 
activities of Lagenaria siceraria fruits and their correlation with 
immunomodulatory activity, as also mentioned by other researchers, further 
uphold our findings. Immunotherapy has been successfully used for the 
  
treatment of allergic rhinitis, allergic asthma, and insect sting (venom) 
sensitivity140. Lagenaria siceraria fruits have also been reported for their anti-
asthmatic and anti-allergic properties. Fruits‟ immune altering potential might be 
held responsible these properties.      
The results obtained in the present study shown that these extract, 
fractions and phytoconstituents display significant immunomodulatory effects. 
Besides the obvious therapeutic importance, these compounds would be useful 
in understanding the mechanism of diseases with higher levels of cellular 
activation, such as autoimmune reactions, hypersensitivity reactions etc. These 
compounds could serve as lead molecules for development of potential 
immunomodulators. Further in depth studies are required to elucidate the exact 
mechanism responsible for immunomodulatory activity of Lagenaria siceraria 
fruits. To the best of our knowledge, for the first time, we reported the 
immunomodulatory property of the fruits of Lagenaria siceraria. The present 
findings are significant for the development of alternative, inexpensive and 
perhaps safer strategies for the treatment diseases requiring use of 
immunomodulatory agents.  Further work on the chemical isolation and structure 
determination of the compounds from bioactive fractions in order to find the 
structure activity relationship is not unjust.     
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7. Conclusion 
Recently phytopharmaceutical research received much attention to develop safe 
and effective lead compounds with potential immunomodulatory activity. The 
present study was planned to isolate phytoconstituents from Lagenaria siceraria 
fruits that may offer immunostimulant or immunosuppressant action.  
Both these effects have significant role in the management of various 
diseases e. g. immunostimulants will be helpful in the prophylaxis and treatment 
of some immuno-compromised diseases such as AIDS etc. and against 
infectious diseases, whereas immunosuppressants would show potential in 
combating autoimmune diseases such as systemic lupus erythmatosus, 
myasthenia gravis as well as hypersensitivity reaction, graft rejection etc. 
 To the best of our knowledge, for the first time, we reported the 
immunomodulatory property of the fruits of Lagenaria siceraria.  
The present study with Lagenaria siceraria fruits leads us to conclude that 
crude methanol extract augments humoral immune response, activates 
macrophage-induced phagocytosis and prevents cyclophosphamide-induced 
myelosuppression. 
Ethyl acetate and n butanol soluble parts of successive methanol extract 
were also found to have immunomodulatory activity, which may account at least 
in part for fruits‟ application in folk medicine.  
Further our results show that Lagenaria siceraria fruits contain flavonoids 
(isoquercitrin, kaempferol), β sitosterol, campesterol and oleanolic acid. This is 
the first report of the presence of isoquercitrin, oleanolic acid and kaempferol in 
the fruits of Lagenaria siceraria. 
 We reported the immunomodulatory property of the oleanolic acid and 
isoquercitrin using different animal models. Study has showed that these 
phytoconstituents augment humoral immune response, suppress cellular immune 
response and activate macrophage-induced phagocytosis. These compounds 
may account at least in part, for the use of Lagenaria siceraria fruits in folk 
medicine to treat various diseases involving immunological backgrounds.  
  
Although no immunomodulatory drug to date have demonstrated 
overwhelming clinical efficacy in the absence of toxicity, our increasing 
knowledge of immunopharmacology is cause for great optimism that future 
agents will provide an important addition to the physician‟s armamentarium. The 
results suggest that Lagenaria siceraria fruits possess promising 
immunomodulatory activity. 
More phytoconstituents can be isolated from the active fractions 
employing variety of solvent systems which can further be investigated for their 
effect on immune system in experimental animals employing more detailed and 
specific tests like cell proliferations, natural killer cell assays etc. These tests are 
highly targeted so they can be performed to fathom exact mode of action of 
different secondary metabolites. This type of approach will get us closer to the 
mechanism of actions of Lagenaria siceraria fruits which can further be 
correlated with other medicinal properties of these fruits. A detailed dose 
dependent study is warranted. Spectroscopic and chromatographic method 
development for saponins and flavonoids will further assist in establishing 
different quality control parameters. Since secondary metabolite content can vary 
as a function of multiple factors (such as environmental conditions and harvest 
period), reproduction of this analysis over a long period of time is of course 
needed before the effectives of our method is totally demonstrated. Extrapolation 
of animal data to a clinical setting is not always appropriate. Nevertheless the 
interesting results, we obtained, indicate that human studies are needed to 
evaluate this fruits for their immunomodulatory studies. The use of Lagenaria 
siceraria fruit as an immunomodulator may be possible in future 
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 Abstract 
An attempt has been made to assess the immunomodulatory activity of 
methanolic extract of Lagenaria siceraria fruits at three dose levels ranging from 
100-500 mg /kg body weight in rats using haemagglutination antibody titre, in 
vivo phagocytosis and cyclophosphamide-induced myelosuppression. Methanolic 
extract increased haemagglutination antibody titre and carbon clearance 
significantly. It also prevented myelosuppression in rats treated with 
immunosuppressive drug-cyclophosphamide. A significant increase in white 
blood cell count was observed in methanolic extract- treated rats as compared 
with cyclophosphamide treatment alone. Methanolic extract and its different 
fractions were also tested phytochemically. It is concluded that Lagenaria 
siceraria fruits possess immunomodulatory activity. 
Key words: Myelosuppression, Immunomodulation, Lagenaria siceraria, 
Phytochemical Screening 
1. Introduction 
Indian medicinal plants are rich source of substances that are claimed to induce immunity 
[1]. Lagenaria siceraria (Molina) Standley (family cucurbitaceae) commonly known as lauki 
(Hindi) and bottle gourd (English) is a medicinal plant [2] and fruits of this plant are 
traditionally used for their cardioprotective, cardiotonic, general tonic, aphrodisiac, diuretic 
and nutritive properties [3]. Fruits are also used in treatment of pain, ulcer, fever, pectoral 
cough, asthma and other bronchial disorders [4]. However there is paucity of data available 
on the effect of the extract of Lagenaria siceraria fruits on humoral immune response, 
cyclophosphamide–induced myelosuppression and phagocytic function of the cells of the 
reticuloendothelial system. Therefore, the present study was undertaken to investigate the 
immunomodulatory effect of methanolic extract of Lagenaria siceraria fruits. 
2. Materials and methods 
2.1 Plant material 
The fresh fruits of Lagenaria siceraria were collected from outfield of Junagadh 
city, Gujarat state, India in March 2007. Plant was authenticated by the authority 
of department of botany, Bahauddin college, Junagadh, where a voucher 
specimen (BS/Bot./I-5/06-07)has been deposited for future reference. 
2.2 Preparation of extract 
  
The coarsely powdered plant material (500g) was defatted with petroleum ether 
and then extracted with methanol in a Soxhlet extractor. The methanol extract 
was concentrated by distilling off the solvents and evaporated to dryness using 
water bath. The residue (69g) was then enriched in flavonoids and saponins by 
suspending in water and extracting successively with ethyl acetate and n butanol 
(3×300 ml each).Resulting solutions were then concentrated to provide ethyl 
acetate soluble (3.2g), n butanol soluble (14.5g) and water soluble (47.3g) 
portions. 
2.3 Phytochemical screening 
Methanolic extract, its ethyl acetate and n butanol soluble fractions were tested 
for the presence of alkaloids, saponins, tannins, flavonoids, anthraquinones and 
sterols according to standard procedures [5]. 
2.4 TLC fingerprint profile 
TLC (silica gel G 60 F254 TLC plates of E. Merck, layer thickness 0.2mm) 
fingerprint profile was established for the ethyl acetate and n butanol soluble 
fractions of methanolic extract of Lagenaria siceraria fruits. Samples were 
spotted on TLC plates using Camag Linomat V automatic sample spotter. 
Solvent systems; n butanol: acetic acid: water (4:1:5) and chloroform: methanol 
(90:10) were used respectively for ethyl acetate and n butanol fractions. The 
plates were scanned using TLC scanner 3 (Camag) at 254nm (absorption mode) 
& 366nm (fluorescence mode) for n butanol fraction and 290nm (absorption) & 
600nm (absorption mode) for ethyl acetate fraction. Rf values and % relative 
areas were recorded from the scanned area. Developed chromatograms were 
then sprayed with vanillin sulphuric acid and heated at 100o C for 10 min.(n 
butanol fraction) and with 1% aluminium chloride solution in methanol and 
observed under uv (ethyl acetate fraction). 
2.5 Experimental animals 
Wister albino rats of either sex and weighing 150 to 180 g were housed in groups 
of four per cage under controlled light (12:12 light: dark cycle) and temperature 
(25 ± 20C) environment and behavioral assessment was conducted during the 
light cycle. Food (Pranav agro sales, Ahmedabad) and water was provided ad 
  
libitum.  All procedures were carried out under strict compliance with ethical 
principles and guidelines of the Institutional Animal Ethical Committee constituted 
as per the direction of the Committee for the Purpose of Control and Supervision 
of Experimental Animals, Madras. All the animals survived the toxicity studies at 
all dose levels. Based on the study; doses of 100,200 and 500 mg/kg were 
selected for animal experiments. 
Methanolic extract of Lagenaria siceraria fruits was suspended in 1% sodium 
carboxy methyl cellulose (SCMC) to prepare different doses from 100 to 500 
mg/kg. The control animals were given an equivalent volume of SCMC vehicle. 
Cyclophosphamide was used as a standard immunosuppressant. Carbon ink 
suspension: Pelican, Germany, ink was diluted eight times with saline and used 
for carbon clearance test (in vivo phagocytosis). 
2.6 Antigen 
Fresh sheep blood was collected from local slaughter house in Alsever‟s solution. 
During the experiment, adequate amount of stock solution (Sheep red blood 
cells, SRBCs, stored in Alsever‟s solution) was taken and allowed to stand at 
room temperature. It was washed three times with normal saline. The settled 
SRBC was then suspended in normal saline and RBC of this suspension was 
adjusted to a concentration of 5x109 /ml for immunization and challenge [6]. 
2.7 SRBC–induced humoral antibody (HA) titre [7] 
Groups of six rats per treatment were immunized by injecting 20 µl of SRBC 
suspension (5x109 SRBC /ml) subcutaneously into right hind foot pad. Seven 
days latter they were challenged by injecting 20 µl of SRBC suspension 
(5x109SRBC /ml) intradermally into the left hind foot pad. The day of 
immunization was referred to as day 0. Blood samples were collected from all the 
animals separately by retro orbital puncture on day +7 (before challenge) for 
primary antibody titre and on day +14 for secondary antibody tire. Antibody levels 
were determined by the method described by Shinde et al. [8].Briefly 25 µl aliquot 
of serum of each animal was taken in microtitre plates. To serial two –fold 
dilutions of pooled serum (made in 25 µl normal saline), 25 µl of 1% v/v SRBC 
suspension (in normal saline) was added. The microtitre plates were kept at 
  
room temperature for 1 h and then observed for haemagglutination (until control 
wells showed unequivocally negative pattern).The value of the highest serum 
dilution showing haemagglutination was taken as the antibody titre. The 
methanolic extract was fed orally once daily, starting with 7 days prior to 
sensitization till the challenge (-7,-6,-5,-4,-3,-2,-1,0,+1,+2,+3,+4,+5,+6,+7). 
2.8 In vivo phagocytosis [9] 
Animals of the treatment group were given methanolic extract daily for 5 days. At 
the end of five days, after 48 hrs., rats were injected via tail vein with carbon ink 
suspension (10 µl/gm body weight).Blood samples were drawn (in EDTA 
solution, 5 µl) from the retro orbital vein at 0 and 15 min.; a 25 µl sample was 
mixed with 0.1%sodium carbonate solution (2 ml) and its optical density was 
measured at 680 nm. The phagocytic index (K) was calculated using the 
equation: K= (logOD1-logOD2)/ 15 Where OD1 and OD2   are optical densities at 0 
and 15 min. 
2.9 Cyclophosphamide-induced myelosuppression [10] 
Animals were divided into five groups of six animals each. Group I (control group) 
and group V (cyclophosphamide treated control) received the vehicle for a period 
of 13 days. Groups II-IV were given methanolic extract daily for 13 days. The 
animals of group II-V were injected with cyclophosphamide (30 mg/kg, i.p.) on 
the 11th, 12th and 13th day, 1 h after the administration of the respective 
treatment. Blood samples were collected on the day 0 and on the 14th day and 
total white blood cell (WBC) count was determined by using a haemocytometer. 
2.10 Statistical analysis 
The values are expressed in mean ± SEM. The results were analyzed by using 
one way analysis of variance (ANOVA) followed by Dunnet‟s t test to determine 
the statistical significance.  P< 0.05 was accepted as statistically significant. 
3. Results 
Preliminary phytochemical screening of methanolic extract showed the presence 
of flavonoids, saponins, sterols, tannins and carbohydrates. n butanol soluble 
fraction found to contain sterols and saponins while flavonoids were found in 
ethyl acetate soluble fraction of methanolic extract. 
  
Methanolic extract of Lagenaria siceraria fruits significantly increased 
haemagglutination antibody titre. Primary antibody titre was found to be 
increased in a dose dependent manner [Table1].The extract also increased rate 
of carbon clearance from rats significantly, indicating increased in vivo 
phagocytosis [Table 2]. 
Methanolic extract prevented myelosuppression in rats treated with 
immunosuppressive drug-cyclophosphamide. A significant increase in white 
blood cell count was observed in methanolic extract treated rats as compared to 
untreated (control) rats [Table 2]. 
4. Discussion 
The results obtained in the present study showed that the extract displays a dose 
dependent immunomodulatory effects. Antibody molecules, a product of B 
lymphocytes and plasma cells, are central to humoral immune response; IgG and 
IgM are the major immunoglobulins which are involved in the complement 
activation, opsonization, neutralization of toxin etc. The antibody production of T 
dependent antigen, SRBCs, requires the co-operation of T and B–lymphocytes 
and macrophages. The augmentation of humoral response by methanolic 
extract, as evidenced by an enhancement of antibody responsiveness to SRBC 
in rats as a consequence of both pre and post immunization extract treatment, 
indicates the enhanced responsiveness of macrophages and B lymphocytes 
subsets involved in antibody synthesis [11]. 
A high degree of cell proliferation renders the bone marrow a sensitive target 
particularly to cytotoxic drugs. In fact, bone is the organ most affected during any 
immunosuppression therapy with this class of drugs. Loss of stem cells and 
inability of the bone marrow to regenerate new blood cells results in 
thrombocytopenia and leucopenia. Administration of methanolic extract of 
Lagenaria siceraria fruits increased the total WBC count, which was lowered by 
cyclophosphamide. The results of the present study indicate that the test drug 
can stimulate the bone marrow activity [10]. 
Phagocytosis by macrophages is important against microorganism and its 
effectiveness is markedly enhanced by opsonization of parasite with antibody 
  
and complement C3b leading to more rapid clearance of parasite from 
blood[6].Administration of methanolic extract enhanced the carbon clearance rate 
from circulation in rats significantly compared to animal of control groups. 
High performance thin layer chromatography was performed to further separate 
components from different fractions of methanolic extract of Lagenaria siceraria 
fruits. TLC fingerprint profile was established for the varied fractions of bioactive 
methanolic extract. Phytochemical screening has shown the presence of 
flavonoids, saponins and carbohydrates. Saponins and flavonoids have long 
been recognized to possess a wide variety of biological activities including 
immunomodulatory property, so the primarily role of these secondary metabolites 
in the said pharmacological activity can not be ruled out [12-15].  
The present study with Lagenaria siceraria fruits leads us to conclude that 
methanolic extract augments humoral immune response, activates macrophage-
induced phagocytosis and prevents cyclophosphamide-induced 
myelosuppression.  
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 Table 1. Effect of methanolic extract of Lagenaria siceraria fruits on SRBC-
induced haemagglutination antibody titre in rats 
 
Values are mean ± SEM, a p>0.05, b p<0.01, c p< 0.05, compared to control group 
animals,(n=6),10 primary,  20 secondary, ME methanolic extract. 
 
Group Treatment 
(mg/kg) 
        Mean haemagglutination antibody(HA) titre 
Range            10 HA titre        Range                     20 HA titre 
Control 
(sensitized) 
- 0-32           32± 0.00               32-64                   37.33±5.33 
ME 100 64-128      117.33±10.66a        64-128              117.33±10.66b 
ME 
ME 
200 
500 
128-256     149.33±21.33a      64-128               106.66±13.49c 
128-512      234.66±61.08b     128-256             213.33±26.98b 
  
Table 2. Effect of methanolic extract of Lagenaria siceraria fruits on in vivo 
phagocytosis and on cyclophosphamide–induced myelosuppression in rats  
Values are mean ± SEM, a p>0.05, b p< 0.01, c p< 0.05 compared to control group 
animals or cyclophosphamide treatment alone, (n=6), CP cyclophosphamide 
 
(Re-revised manuscript in under consideration in Journal of Natural Remedies.)  
Group      Treatment                          
(mg/kg) 
Phagocytic 
index(K) 
Total WBC 
(103/mm3) 
Day 0 
Total WBC 
(103/mm3) 
Day 14 
Control         - 0.0221±0.000 9.99±0.16 10.4±0.51 
ME 100 0.0228±0.001a 10.15±0.23 6.99±0.34 a 
ME   200 0.0326±0.001b 10.11±0.12 8.85±0.38 c 
ME   500 0.0438±0.001b 10.15±0.21 10.78±0.28 b 
CP 30 - 9.97±0.19 6.32±1.09 
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